CA1335894C - Inosose derivatives and production thereof - Google Patents

Inosose derivatives and production thereof

Info

Publication number
CA1335894C
CA1335894C CA000531094A CA531094A CA1335894C CA 1335894 C CA1335894 C CA 1335894C CA 000531094 A CA000531094 A CA 000531094A CA 531094 A CA531094 A CA 531094A CA 1335894 C CA1335894 C CA 1335894C
Authority
CA
Canada
Prior art keywords
amino
formula
group
compound
hydroxyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000531094A
Other languages
French (fr)
Inventor
Hiroshi Fukase
Satoshi Horii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of CA1335894C publication Critical patent/CA1335894C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/60Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/385Saturated compounds containing a keto group being part of a ring
    • C07C49/517Saturated compounds containing a keto group being part of a ring containing ether groups, groups, groups, or groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

wherein y1 stands for hydroxyl group and y2 stands for hydrogen atom, or y1 and y2 are jointly combined to be a bond between carbon and carbon atoms, and R1 is a protective group for hydroxyl group, are useful as a starting material for producing valienamine, valiolamine and their N-substituted derivatives.
Valienamine, valiolamine and their N-substituted derivatives have an inhibitory activity against .alpha.-glucosidase and are useful as prophylactic or therapeutic agents of hyperglycemic symptoms in man and other animals and various disorders caused by hyperglycemia such as diabetes, obesity, hyperlipemia, etc.

Description

- l 133S89~
INOSOSE DERIVATIVES AND PRODUCTION THEREOF

Valienamine, valiolamine and their N-substituted deriva-tives [J. Antibiot., 35, pp. 1624-1626 (1982); J. Anti-biot., 37, pp. 1301-1307 (1984); Carbohydr. Res., 140, pp. 180-200 (1985); J. Med. Chem., 29, pp. 1038-1046 (1986)] have an inhibitory activity against ~-glucosidase and are useful as prophylactic or therapeutic agents of hyperglycemic symptoms in man and other animals and various disorders caused by hyperglycemia such as diabetes, obesity, hyperlipemia, etc. The novel inosose derivative CH2oRl y2 ~yl ~ ORl ~=O [I]

R10 \1 OR

wherein yl stands for hydroxyl group and Y2stands for hydrogen atom; or yl and y2 together form a chemical bond between the carbon atomSto which they are attached, and Rlis a protective group for hydroxyl group, are important compounds as starting materials for producing valienamine, valiolamine and their N-substituted derivatives.
The present inventors previously found that valienamine and valiolamine can be isolated from a culture broth of Streptomyces hygroscopicus subsp.
limoneus [J. Antibiot. 37, pp. 1301-1307 (1984)];
valienamine can be prepared by subjecting validamycins or validoxylamines to microbiological degradation _,~
-2- 133589~

[Toku-Kai Sho (Japanese Patent Application Laid-Open No.) 57-54593 and 58-1524961]; and valiolamine can be synthesized from valienamine [Carbohydr. Res., 140 pp.
180-200 (1985); EP 63,950 (1982); U.S. P. 4,446,319, 5 (1984)].
On the other hand, the following methods of preparing DL-valienamine and DL-valiolamine by chemical synthesis were reported; the method of preparing DL-valienamine via DL-1,2,3-tri-O-acetyl-(1,3/2,4,6)-4-10 bromo-6-bromomethyl-1,2,3-cyclohexanetriol as the intermediate ~T. Toyokuni et al. Bull. Chem. Soc. Jpn., 56, pp. 1161-1170 (1983)]; the method of preparing DL-valienamine via DL-2,3-di-O-acetyl-1,7-O-benzylidene-(1,3,4/2,5,6)-4-azido-6-(hydroxymethyl)-1,2, 15 3,5-cyclohexanetetrol as the intermediate [S. Ogawa et al.
J. Org. Chem., 48, pp. 1203-1207 (1983)]; the method of preparing DL-penta-N,O-acetylvaliolamine via DL-1,2,3-tri-O-acetyl-(1,3:/2,4)-4-bromo-6-methylene-1,2,3-cyclohexanetriol as the intermediate [S. Ogawa 20 et al. Chem. Lett., pp. 1581-1582 (1985)]. However, the processes of resolution of the DL mixtures have not yet been established in these methods.
As a method of preparing enantiomerically pure natural-type valienamine by chemical synthesis, the 25 method from L-(-)-quebrachitol was reported ~H. Paulsen, F. R. Heiker, Justus Liebigs Ann. Chem. 1981, pp.
2180-2203], but this method comprises a number of steps, which is not necessarily suitable for industrial production of valienamine. Besides, the method of 30 synthesizing N-substituted valienamine derivatives from D-glucose via lD-(1,3,6/2)-4-benzoyloxymethyl-6-bromo-1,2,3-tri-O-benzyl-4-cyclohexene-1,2,3-triol and its lD-(1,3/2,6)-isomers ~N. Sakairi, H. Kuzuhara, Tetrahedron Lett., 23, pp. 5327-5330 (1982)] was 35 also reported.

However, these above-mentioned total chemical syntheses of valienamine and valiolamine have such drawback as poor stereospecific processes, difficulties in availavility of materials or comprising a number of reaction steps, and these methods are hardly considered industrially suitable.
A direct fermentation method of valienamine and valiolamine, namely, a method of isolating from the fermentation broth of Streptomyces hyqroscopicus subsp.
limoneus, is most convenient and simple one, but, this method is not satisfactory yet at the present state in respect to the yield as an industrial method.
The method of preparing valienamine by micro-biological degradation of validamycins, especially validamycin A is most excellent as an industrial method.
However, this method has such a drawback as a part of constituents of validamycin A is utilizable for the purpose of preparing valienamine (the molecular weight of valienamine is about 1/2.7 relative to validamycin A), which makes the resultant valienamine comparatively expense.
On the other hand, the present inventors found out methods of preparing N-substituted derivatives of valienamine and valiolamine by subjecting the amino group of valienamine and valiolamine to reductive alkylation with aldehydes or ketones, or by allowing the amino group of valienamine and valiolamine to react with an oxirane derivative or a halogen derivative [J. Antibiotics, 35, pp. 1624-1626 (1982); J. Med.
Chem., 29, pp. 1038-1046 (1986); EP 56194 (1982) and 89812 (1983)], and valiolamine has been exclusively employed as the material for preparing N-substituted valiolamine derivatives so far. Circumstances being such, more advantageous methods for synthesizing valienamine, valiolamine and N-substituted valiolamine derivatives have been desired.
The present inventors eXpected that, if an inosose derivative could be used as the material for constructing the valiolamine moiety of N-substituted valiolamine derivatives, it would be possible to employ a primary amine having the corresponding structure as the material for constructing the N-substituent moiety, and when this primary amine is available more advantageously than the corresponding aldehydes, ketones, oxiranes and halides, the end product would be prepared more advantegeously by this method than the method in which valiolamine is employed as the material.
Thus, the present invention relates to an inosose derivative of the formula C~2Rl y 2 /11 <
~ ORl > =o [I]

ORl wherein yl stands for hydroxyl group and Y stands for hydrogen atom, or Y and Y together form a chemical bond between the carbon atoms~ to which they are attached~
and R is a protective group for hydroxyl group.
Under the circumstances as above, the present inventors have conducted diligent investigation for solving the aforementioned problems and have succeeded in preparing novel inosose derivatives of the general formulaO

/OH
~ORI ~ O [I']
R10\1 ORI
10 [wherein Rl stands for a protective group for hydroxyl group] by using, as the material, sedoheptulosan (2,7-anhydro-~-D-altro-2-heptulopyranose), which is 2,7-anhydro-sugar of sedoheptulose (D-altro-2-heptulose), then have succeeded in preparing pseudo-amino sugars or 15 derivative thereof having the general formula: .

20 ~OR3 ~ ~H-A [III]

twherein R3 stands for a hydrogen atom or a protective group for hydroxyl group, A stands for an amine residue or hydrogen atom, and the wavy bond ~-~shows R- or S-configurational bond], by reacting a compound ~I']
with a primary amine or hy-droxylamine having the general formula R -NH2 rII~Cwherein 30 R stands for an amine residue or hydroxyl group~, and then reducing the resultant Schiff's base, fol-lowed by, when desired, depratection reaction.
~ he present inventors have further conducted diligent investigation for solving the aforementioned 35 problems and have succeeded in preparing novel com-pounds having the general foxmula:

6 1 1 335~9~ 24205-718 C~H2R
~ o 1~
~ oRl ~ CH2P(OR )2 [VIII]
R O ~

[wherein Rl stands for a protective group for hydroxyl group, and R5 stands for a hydrocarbon residue] by employing as the startlng material readlly avallable and less expenslve D-glucose or D-glucono-1,5-lactone (D-gluconlc acld ,~-lactone) whlch can be easlly prepared from D-glucose, and then have succeeded ln preparing novel unsaturated lnosose derlvatives having the general formula: .

~ [I']

R O =
ORl [wherein Rl stands for a protective group for hydroxyl group], whlch can be an lmportant intermedlate for the synthesls of vallenamlne, by subiectlng the compound [VIII] to the treatment wlth a base.
In the general formula [II], R2 stands for an amlne resldue or hydroxyl group, and the typical amine resldues are cycllc or acycllc hydrocarbon resldues of 1-7 carbon atoms optlonally having optionally protected hydroxyl group and/or optlonally substltuted phenyl group.
Prlmary amlnes representable by the general formula;

R -NH2 are practlcally exempllfled by acycllc alkyl X

133S89~
amines optionally having hydroxyl group and/or optionally substituted phenyl group, such as ethanolamine, 3-amino-1-propanol, 2-amino-1-propanol, 2-amino-1,3-propanediol, 1-amino-2-propanol~ 2-amino-3-hydroxy-1-butanol, tristhydro-xymethyl)aminomethane, 2-amino-2-methyl-1,3-propanediol, 2-amino-2-methyl-1-propanol, 2-amino-3-methyl-1-butanol, 3-amino-1,2-propanediol, 4-amino-1,2- butanediol, 2-amino-1-butanol, 2-amino-1,4-butanediol, 2-amino-1,5-pentanediol, 5-amino-1-pentanol, 6-amino-1-hexanol, methylamine, ethyl-10- amine, propylamine, butylamine, benzylamine, phenethylamine, aminodiphenylmethane, 2-amino-l-phenylethanol, 2-amino-2-phenylethanol, 2-amino-3-phenyl-1-propanol, 2-amino-3-hydroxy-3-phenyl-1-propanol, 2-amino-3-(4-hydroxyphenyl)-l-propanol, ~-amino-~-methylphenethylalcohol, etc.; amino-deoxy-alditols, such as l-amino-l-deoxy-D-glucitoll 2-amino-2-deoxy-D-slucitol~ l-amino-l-deoxy-D-mannitol, 2-amino-2-deoxy-D-galactitol, l-amino-l-deoxy-D-ribitol, 4-amino-4-deoxy-D-erythritol, etc.; cyclic alkylamines optionally substituted with hydroxyl group and/or phenyl group, such as trans-2-aminocyclohexan-1-ol, trans-3-aminocyclohexan-1-ol, cis-3-aminocyclohexan-1-ol, trans-2-amino-1-phenylcyclo-hexan-1-ol, cis-2-amino-1-phenylcyclohexan-1-ol, cyclohexyl-amine, cyclopentylamine, 1-amino-1-cyclopentane methanol, 2-aminocyclopentanol, etc.; inosamines such as myo-inosamine-1, myo-inosamine-2, myo-inosamine-4, neo-inosamine-2, epi-inosamine-2, muco-inosamine-3, scyllo-inosamine, etc.;
C-(aminomethyl)inositols such as 2-(aminomethyl)myoinositol, etc.; diaminocyclitols such as streptamine, deoxystreptamine, fortamine, sporamine, istamine, etc.; pseudo-amino sugars such as valienamine, validamine, hydroxyvalidamine, valiolamine, 2-hydroxy-4-(hydroxymethyl)cyclopentylamine, etc. Hydroxyl groups of the above-mentioned compounds may optionally be protected. In the above-mentioned formulae [~] and [m], the amine residue represented by A is practically exempli-fied by all of the amineresidues (i.e. R2) of amines setforth as primary amines representable by the above R2-NH2.

-8- 133589~

As the protective group for hydroxyl represented by Rl and R3 in the above formulaeI~ ,II'~ and IIII], use is made of protective groups in the chemistry of sugars, such as acyl type protective groups, ether type protective groups, acetal type protective groups, ketal type protective groups or orthoester type protective groups.
The acyl type protective groups include e.g. alkanoyl groups of 1 to 5 carbon atoms which may be substituted by halogen~ lower alkoxyl of 1 to 5 carbon atoms or phenoxy optionally having halogen; benzoyl groups which may be substituted by lower alkyl of 1 to 5 carbon atoms which may be substituted by nitro, phenyl or halogen or lower alkyloxy-carbonyl of 2 to 6 carbon atoms; alkoxycarbonyl of 2 to 6 sarbon atoms which may be substituted by halogen; alkenyloxy-carbonyl of 3 to 5 carbon atoms; benzyloxycarbonyl groupswhich may be substituted by lower alkoxyl of 1 to 5 carbon atoms or nitro; phenoxycarbonyl substituted by nitro; etc.
As the halogen, use is made of fluorine, chlorine, bromine or iodine; as the alkyl of 1-5 carbon atoms, use is made of, for example, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec.-butyl, tert-butyl, pentyl, isopentyl, neopentyl etc. ; as the alkanoyl of 1 to 5 carbon atoms, use is made of, for example, formyl, acetyl, propionyl, butyryl, iso-butyryl, isovaleryl, pivaloyl etc.; as the alkoxyl of 1 to 5 carbon atoms, use is made of, for example, methoxyl, ethoxyl, propoxyl, pentyloxy, vinyloxy, allyoxy, etc. which may be substituted by halogen.
As the alkenyl of 2-4 carbon atoms in the above alkenyl-oxycarbonyl of 3-5 carbon atoms, use is made of, for example, vinyl, allyl, isopropenyl, l-propenyl, l-butenyl, 2-butenyl, 3-butenyl, etc.
More concretely, the examples of acyl type protective groups are formyl, acetyl, chloroacetyl, dichloroacetyl, trichloroacetyl, trifluoroacetyl, methoxyacetyl, triphenyl-methoxyacetyl, phenoxyacetyl, p-chlorophenoxyacetyl, propionyl, isopropionyl, 3-phenylpropionyl, isobutyryl, pivaloyl; benzoyl, p-nitrobenzoyl, p-phenylbenzoyl, o-- (dibromomethyl)benzoyl, o-(methoxycarbonyl)benzoyl, 2,4,6-trimethylbenzoyl; methoxycarbonyl, ethoxycarbonyl, 2,2,2-trichloroethoxycarbonyl, isobutyloxycarbonyl; vinyloxy-carbonyl, allyloxycarbonyl; benzyloxycarbonyl, p-methoxy-benzyloxycarbonyl, 3,4-dimethoxybenzyloxycarbonyl, p-nitro-benzyloxycarbonyl; p-nitrophenoxycarbonyl, etc.
The ether type protective groups include, for example, lower alkyl groups of 1-5 carbon atoms which may be substi-tuted by halogen, lower alkoxyl of 1-5 carbon atoms, benzyl-oxy or phenyl; alkenyl groups of 2-4 carbon atoms; tri-substituted silyl groups substituted by lower alkyl of 1-5 carbon atoms, phenyl, benzyl, etc.; benzyl group which may be substituted by lower alkoxyl of 1-5 carbon atoms or nitro; tetrahydropyranyl group or tetrahydrofuranyl group, which may be substituted by lower alkoxy of 1-5 carbon atoms or halogen.
As the above-mentioned halogen, lower alkyl groups of 1-5 carbon atoms, lower alkoxyl groups of 1-5 carbon atoms and alkenyl groups of 2-4 carbon atoms, use is made of ones similar to those used in the case of the acyl type protective groups.
More concretely, the ether type protective groups are methyl, methoxymethyl, benzyloxymethyl, tert-butoxymethyl, 2-methoxy-ethoxymethyl, 2,2,2-trichloromethoxymethyl, ethyl, 1-ethoxy-ethyl, 1-methyl-1-methoxyethyl, 2,2,2-trichloroethyl, propyl, isopropyl, butyl~isobutyl, sec-butyl, tert-butyl, ethoxy-ethyl, triphenylmethyl, p-methoxyphenyldiphenylmethyl;
allyl; trimethylsilyl, tert-butyldimethylsilyl, tert-butyl-diphenylsilyl; benzyl, p-methoxybenzyl, p-nitrobenzyl, p-chlorobenzyl; tetrahydropyranyl, 3-bromotetrahydropyranyl, 4-methoxytetrahydropyranyl, tetrahydrofuranyl, etc.
The acetal type, ketal type and orthoester type protec-tive groups are preferably those of 1 to 10 carbon atoms.Specific examples of them are methylene, ethylidene, 1-tert-butylethylidene, 1-phenylethylidene, 2,2,2-trichloroethyl-idene; isopropylidene, butylidene, cyclopentylidene, cyclo-hexylidene, cycloheptylidene; benzylidene, p-methoxybenzyl-idene, 2,4-bromomethoxybenzylidene, p-dimethylaminobenzyl-idene, o-nitrobenzylidene; methoxymethylene, ethoxymethylene, dimethoxy-methylene~-l-methoxyethylidene~ 2-dimethoxyethylidene~ etc.
Further, stannoxane type protecting groups such as dibutylstannyl, tributylstannyl, cyclic carbonate type protecting groups, cyclic boronate type protecting groups, etc. can be used likewise.
Types of the protective groups for hydroxyl group repre-sented by R1 and R3 may be one and the same or may contain two or more diffrent ones. Further, as in the cases of cyclic acetal, cyclic ketal, cyclic orthoester, cyclic carbonate, cyclic boronate and stannoxane type protective groups, two hydroxyl groups may be protected with a one protective group.
It has been known that sedoheptulose, a starting material of the compound [I'], is accumulated in a culture broth of microorganisms such as a certain species of bacteria, actimomycetes, etc. [cf. e.g. J. Biochem.
(Tokyo), 54, pp.107-108 (1963); Japanese Patent Appl.
Publication No. 5240/1982], and sedoheptulose can be purified and isolated from the culture broth of these microorganisms. Further, by heating sedoheptulose in a dilute mineral acid e.g. dilute sulfuric acid, sedoheptulosan (2~7-anhydrosedoheptulose) can be isolated as crystals. Preparation of D-idoheptulosan(2,7-anhydro-~-D-ido-2-heptulopyranose) from sedoheptulosan can be conducted by, for example, the reaction steps as shown in Scheme 1 :
i) protecting the hydroxyl groups at 4- and 5-position of sedoheptulosan with a protecting group e.g. isopropyl-idene group, ii) protecting the hydroxyl groups at 1- and 3-position with e.g. benzoyl group (Bz), iii) removing the protecting groups for hydroxyl groups at 4- and 5-position, iv) protecting the hydroxyl group at 4-position with a ll- 133S89~

protecting group e.g. benzoyl group, v) organosulfonylating, for example, imidazolylsulfonylat-ing the hydroxyl group at 5-position, vi) inverting configuration of the hydroxyl group at 5-position by reacting with acyloxy anion e.g.
benzoyloxy anion, and vii) removing the protecting group for hydroxyl group, when necessary.
Scheme 1 NO~ ~O~CN20N ~ NO~CN20N o , ~O~CN20B-~0 ,--0 iv) / \ v) HO~ BZO~CH20Bz H ~ BZO~CH20Bz OH OBz ~ 0~ vi) BzO

~SO20~ BZ~CH20Bz ~ BZO~CH OB
OBz OBz HO ~ \
HO~CH2OH
OH

-12- - I 33~89~
Method of pre~r; ng D-idohept~ n (2,7-anhydro-~-~ido-2-heptulo-pyranose) and its 1,3,4,5-tetra-O-acetyl derivatives via 2,7-anhydro-~-D-arabino-2,5-heptodiulopyranose from sedo-heptulosan are reported by K. Heyns et al. [Chem. Ber., 5 108, pp.3611-3618 (1975)], and a method of preparing D-idoheptulose and 2,7-anhydro-~-D-idoheptulopyronose by subjecting D-gluco-D-ido-heptitol to microbiological oxi-dation are reported by J. W. Pratt [J. Am. Chem. Soc., 74, pp. 2210-2214 (1952)]. By resorting to these known methods, D-idoheptulosan [compound [VII] wherein Rl = H in Scheme 2] and D-idoheptulosan whose hydroxyl group is protected by a hydroxy protective group can be prepared as well.
Methods of preparing the compound [I'] from D-idoheptulosan [VII~ [compound [VII] wherein Rl=
protective group for hydrohyl group] are described in detail as follows. In the formulae [I'], [II] to [VII]
in Scheme 2, Rl, R2, R3 and A are of the same meaning as defined above, R4 stands for hydrogen or a protective group of anomeric hydro~yl group; X stands for halogen atom such as iodine, bromine, chlorine, fluorine, schem~ 2 CH2 CH20H
~ \ Step A-l R'O ~ \ ~ OR~ Step A-2>
~ CH20RI ~ CH20R

[VII] [VI]

30 RlO~ OR~ Ste? A-3 R O ~ OR Step A-4 [V] [IV]

RIO ~ ON R~ ~H Step A-> ~ H-A

[I'] [III]

-13- 133589~

Step A-l The compound [~] can be prepared by subjecting 2,7-anhydro linkage of the compound [UI] to cleavage reaction.
A preferable example of the protective group for hydroxyl group represented by R1 of the compound [~] is benzoyl.
For performing this cleavage reaction of anhydro linkage, conventional methods for cleavage of anhydro linkage of sugars [cf. for example the review articles titled "1,6-anhydro derivatives of aldohexoses~ by M. Cerny and J.
Stanek Jr., in Adv. Carbohyd. Chem. Biochem. 34, pp. 63-69 (1977)] are employed. The cleavage of anhydro linkage is conducted in the presence of, for example, an acid. As suitable acids are ~XP~lif;~ inorganic acids such as sulfuric acid, hydrogen chloride (hydrochloric acid), hydrobromic acid (hydrogen bromide), nitric acid, perchloric acid, etc.; organic acids such as p-toluenesulfonic acid, acetic acid, acetic anhydride, trifluoroacetic acid, trifluoroacetic anhydride, etc.;
Lewis acids such as boron trifluoride, boron trichloride, boron tribromide, zinc chloride, aluminium chloride, titanium tetrachloride, stannic chloride, phosphorus pentachloride, phosphorus pentabromide, phosphorus pentoxide, etc. These acids can be used singly or in admixture of two or more of them.
This cleavage reaction is usually conducted in a solvent.
In this case, some solventc can be used for dual purposes of acting as solvent'and reaction reagent. As the solvent can be used water, methanol, ethanol, propanol, trimethoxymethane, ethyl ether, chloroform, dichloro-methane, acetone, acetic acid, trifluoroacetic acid, acetic anhdyride, trifluoroacetic anhydride and any other solvent which does not exert an adverse influence on the reaction, singly or as a mixed solvent. As preferable processes can be mentioned a process comprising reaction with trimethoxy-methane and zinc chloride in methanol, reaction with tri-fluoroacetic acid and trifluoroacetic anhydride in a tri-methoxymethane solution, etc., and in these cases, compounds -14- 133~89~

whose R4 is methyl are obtained. The reaction temperature is not particularly limitative, and the reaction is conducted under cooling, room temperatures or under heating.
After the reaction, when necessary, removal of a protective group for hydroxyl group containing anomeric hydroxyl group and re-introduction thereof may be conducted Step A-2 The compound [V] can be prepared by subjecting the compound [VI] to halogenation- (While secnn~ry hydroxyl groups of C-3, C-4 and C-5 are not always necessary to be protected, the primary hydroxyl group of C-l and the anomeric hydroxyl group of C-2 are desirably protected.) The halogenation can be conducted by resorting to con-ventional methods of halogenation of hydroxyl groups of sugars [cf. for example, the review articles titled "Some Approaches to the Synthesis of Halodeoxy Sugars" by S. Hanessian in Advances in Chemistry Series 74; Deoxy Sugars, pp. 159-201(1968), edited by American'Chemical Society and-the review article5 titled "Deoxyhalogeno Sugars" by W. A. Szarek in Adv. Carbohydr. Chem. Biochem., 28, pp.225-306 (1973)].
Methods of halogenation suitable for this halog~nation are exemplified by a method comprising allowing phosphines such as triphenyl phosphine to react with N-halogenosuccinimide such as N-iodosuccinimide, N-bromo-succinimide, N-chlorosuccinimide, etc., preferably N-iodo-succinimide, and a method comprising activating hydroxyl group by sulfonylating with an organic sulfonyl group such as p-tolylsulfonyl, methylsuflonyl, trifluoromethanesulfonyl, imidazolylsulfonyl group, etc., followed by allowing to react with a halogenated metal MX (M stands for alkali metal such as lithium, sodium, potassium, etc., and X stands for halogen atom such as fluorine, chlorine, bromine, iodine, etc.), preferably sodium iodide.
The halogenation is conducted usually in a solvent. The solvent is exemplified by N,N-dimethylformamide, dimethyl-~ -15- 1 33589~
sulfoxide, pyridine, acetone, 2,4-pentanedione, 2-butanone, ethylene glycol, methanol, ethanol, glycerol, dioxane, tetra-hydrofuran, chloroform, tetrachloroethane, carbon tetra-chloride, benzene, etc. Besides, solvents which do not exert untoward influence upon the reaction can be employed singly or an admixture. The reaction temperature is not particularly limitative, and the reaction is conducted under cooling, room temperature or under heating.
Step A-3 The 6,7-unsaturated compound [IV] can be prepared by subjecting the 7-halogeno compound [V] to dehydrohalogenation.
This elimination reaction of hydrogen halogenide can be conducted by resorting to conventional methods [cf. for example, the review articles on ~'Synthesis and Reactions of Unsaturated Sugars" by L. Hough described on Advances in Chemistry Series 74: Deoxy Sugars, pp.l20-140 (1968), edited by American Chemical Society]. This reaction is conducting by, preferably, allowing the compound [V] to react with anhydrous silver fluoride in pyridine.
Step A-4 For example, compound [I~ can be prepared by treating compound [IV] with mercury (II) salts such as mercury (II) chloride, mercury (II) acetate, mercury (II) trifluoroacetate,mercury (II) sulfate etc. in an aqueous organic solvent such as aqueous acetone. The reaction temperature is usually in the range of 10C to the refluxing temperature of the reaction solvent. The reaction time is usually in the range of 2 to 10 hours, although it depends on the reaction temperature.
Step A-5 The pseudo-amino sugar representable by the general formula [m] (wherien A stands for amine residue R3 and the wavy bond ~_- are of the same meaning as defined in the foregoing) can be prepared by subjecting the Schiff base obtainable by allowing the compound [I'~ to react with a primary amine representable by the general formula [~]
(wherein R2 stands for amine residue) to reduction, followed by, when desired, subjecting the resultant to a reaction for removing the protective group.

The above-mentioned Schiff base formation reaction and reduction of thus formed Schiff base can be conducted in a continuous manner in one and the same reaction vessel.
The condensation reaction of the compound [I'j and the above-mentioned primary amine [IIj and the reduction of the resultant Schiff base are conducted generally in a solvent. Examples of suitable solvents are water;
alcohols such as methanol, ethanol, propanol, butanol, etc.; dimethyl sulfoxide, N,N-dimethylformamide; N-methylacetamide; glymes such as methyl cellosolvedimethyl cellosolve, diethylene glycol dimethyl ether, etc.; and a mixture of these solvents. In addition, a mixture of the above-mentioned solvent and an aromatic hydrocarbon, such as benzene, toluene etc., or an ester, such as ethyl acetate etc., may be used.
The reaction temperature of the Schiff base forming reaction is not particularly limitative, and the reaction is usually conducted in the range of room temperatures to about 100C. The reaction time varies with the reaction temperature, and usually several minutes to about 24 hours reaction is sufficient for attaining the purpose.
For carrying out the reduction of thus-formed Schiff base, are advantageously employed various metal complex hydride reducing agents, for example, alkali metal borohydride such as sodium borohydride, potassium borohydride, lithium boro-hydride, sodium trimethoxyborohydride, etc., alkali metal cyanoborohydride such as sodium cyanoborohydride, alkali metal aluminium hydride, etc., dialkyl amine borane such as dimethylamine borane, etc. Additionally stating, when alkali metal cyanoborohydride e.g. sodium cyanoboro-hydride is used, the reaction is conducted preferably under acid condition, for example, in the presence of hydrochloric acid, acetic acid, etc.
Reaction temperature of this reduction is not particular-ly limitative, and the reaction is conducted usually atroom temperatures, and, depending on cases, under ice-cooling especially at the initial stage of the reaction, and also, -17- 133589~

depending on cases, under heating to about 100C. Practi-cally, the reaction temperature varies with the kindsof Schiff base to be reduced and reducing agents to be employed.
The reaction time also varies with the reaction temperature and with the kinds of Schiff base to be reduced and reducing agents, and the reaction for several minutes to about 24 hours is enough to attain the purpose.
As the reduction of the Schiff base thus-formed, a means of catalytic reduction can also be employed. More concretely, the catalytic reduction is conducted by subjecting the Schiff base to shaking or stirring in a suitable solvent in a stream of hydrogen in the presence of a catalyst for catalytic reduction. As the catalyst, use is made of, for example, platinum black, platinum dioxide, palladium black, palladium carbon, Raney nickel, etc. As the solvent to be usually employed are mentioned, for example, water; alcohols such as methanol, ethanol, etc.; ethers such as dioxane, tetrahydrofuran, etc., N,N-dimethylformamide or a mxiture of them. The reaction is conducted at room temperature under atmospheric pressure, but the reaction may be conduct-ed under elevated pressure and by heating.
The compound [m] wherein A is hdyrogen atom can be prepared by, for example, allowing the compound ~I']to react with the compound [~] wherein R2 is hydroxyl group, i.e.
hydroxylamine to give an oxime, followed by subjecting the oxime to reduction. Alternatively, instead of hydroxylamine, O-substituted hydroxylamine such as O-methylhydroxylamine or O-benzylhydroxylamine is allowed to react with the compound [I'],followed by subejcting the resultant O-alkyl oximes or O-aralkyl oximes to reduction. The reduction of hydroxyimino group of the oximes thus obtained to amino group can be conducted before or after removal of the of the protective group for hydroxyl group of the cyclitol moiety.
The reduction can be conducted by subjecting to catalytic reduction in a suitable solvent using a platium catalyst 133589~
such as platinum oxide, etc., palladium catalyst such as palladium carbon, etc., nickel catalyst such as Raney nickel, etc., rhodium catalyst such as rhodium carbon, etc. or by subjecting to reduction in a suitable solvent using an aluminium hydride compound such as lithium aluminium hydride, etc., more preferably, in an atmosphere of an inert gas such as nitrogen, argon, etc. The compound [m], wherein A is hydrogen atom, can also be prepared starting from the compound [I'],via a compound [III], wherein the A moiety is a substituent e.g. benzyl group, p-methoxybenzyl group, 3,4-dimethoxybenzyl group or di(p-methoxyphenyl)methyl group conventionally employable as protecting groups for amino group, then by subjecting the resultant to a conventional reaction for removing the pro-tecting group for amino group, exemplified by hydrogenolysis by means of catalytic reduction, reaction with metallic sodium in liquid ammonia, reaction with an acid (e.g.
concentrated sulfuric acid-trifluoroacetic anhydride, acetic acid, trifluoroacetic acid, formic acid, etc.), etc.
When the compound [ m ] has protected hydroxyl groups, removal of the protective groups for hydroxyl groups can be conducted by resorting to a ~ se conventional method.
For example, acetal type protective groups such as cyclo-hexylidene group, isopropylidene group, benzylidene group, etc. or trityl group can be removed by subjecting them to hydrolysis with an acid such as hydrochloric acid, acetic acid, sulfonic acid type resin, etc.; acyl type protective groups such as acetyl group, benzoyl groups, etc. can be removed by subjecting them to hydrolysis with an alkali such as ammonia sodium hydroxide, barium hydroxide, sodium meth~xi~P, etc.; and benzyl ether type protective groups such as benzyl group, p-methoxybenzyl group, etc. can be removed by subject-ing then to hydrogenolysis by means of catalytic reduction or by subjecting them to reductive cleavage with metallic sodium in liquid ammonia; etc.

lg- 1335894 Concrete description of the method of preparing the compound [I"] and the method of preparing valienamine from the compound [I"] is given below, and the schema of the produciton steps are shown in Scheme 3 and Sheme 4.
In each of the schema, Rl stands for a protecting group for hydroY~yl, R5 stands for a hydrocarbon residue and R6 stands for an organic residue of organic sulfonyl group.

Scheme 3 Step B-l ~ \ OH
15I~ORI ~ O >
R10 ~ R10 ~ CH2P(OR5)2 (1) (2) OR

CH20Rl OH OH
Step B-2 / ~ Step B-3 > ~\ORI ,5 CH2P(OR5)2 - `
R10 \1 (3) OR

R'O ~ ~ CH2P(ODs~2 Step s-4 ORl ~"]
[VIII]

I 33589q Scheme 4 ~ \ Step B-5 > ~OH S~ep B-6 ~ORI ~ , ~OR
R10 \1 ~ R'O \l ORI OR
[ I '~ (4) ~OR~ ~ Step B-~ ~OR' ~ Step B-~

ORI OR
(5) (6) > \Step B-9 - ~ \
~ OR ' ~ ~ ~ OH i RlO ~ ~ NH2 HO~ ~NH2 OR ' OH
(7 a) (7 b) In the general formula [I ]1, the general formula [VIII] and other formulae shown in Scheme 3 and 4, as the protective groups for hydroxyl group shown by R1, use is advantageously made of protective groups which are employed as hydroxyl-protective group in the chemistry of sugars, for example, ether type protective groups, acetal type protective groups, ketal~
type protective groups, orthoester type protective groups.

-21- 133S89~

In the general formula [VIII], as the hydrocarbon residues representable by R5 are mentioned, for example, alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, etc., aryl groups such as phenyl, etc., aralkyl groups such as benzyl, etc., and a lower alkyl group of 1-4 carbon atoms is conveniently employed.
The compounds [ I" ] can be synthesized by employing a glucono-1,5-lactone derivative (1) as the starting material through the following steps B-l to B-4, namely;
Step B-l allowing phosphonate carbanion, which is obtainable by subjecting methyl phosphonic acid ester represented by the general formula CH3P(o)(oR5)2 [IX] (wherein R5 stands for hydrocarbon residue) to the treatment with a base, for example, n-butyllithium, to react with a glucono-1,5-lactone derivative (1) to give a l-deoxyl-l-phosphoryl-D-gluco-2-heptulopyranose derivative (2), Step B-2 subjecting the carbonyl group forming the hemiketal of the compound (2) to reduction into hydroxyl group to thereby open the pyranose ring to give a heptitol derivative (3), Step B-3 oxidizing the hydroxyl groups at 2- and 6-position of the compound (3) into carbonyl group to give a l-deoxy-l--- 2~ -phosphoryl-D-xylo-2,6-heptodiulose derivative [V m], and Step B-4 treating the compound [VIII] with abase to give a 4L-4,6/5-trihydroxy-3-hydroxymethyl-2-cyclohexenone derivative [I"].
Valienamine and derivatives thereof can be synthesized by, for example, as shown in Schme 4, employing the compound [I"]as the starting material through the following steps B-5 to B-9, namely;
Step B-5 reducing the carbonyl group of the compound [I"] to hydroxyl group to give an L-(1,3/2,4)-5-hydroxymethyl-5-cyclohexene-1,2,3,4-tetrol derivative (4), Step B-6 subjecting the hydroxyl group at l-position of the com-pound (4) to organo-sulfonylation to give a compound (5), Step ~-7 substituting the organo-sulfonyloxy group of the compound (5) with azido group to give an azido-derivative (6), Step B-8 and Step B-9 reducing the azido group of the compound (6) to amino group, followed by, when necessary, removing the hydroxyl-protective group to give valienamine and its derivatives.
Alternatively, in place of Step B-2 and B-3, the compound (2) is treated with a base such as sodium hydride, potassium tert-butoxide, etc. to convert the carbonyl group o hemi-ketal type into enolate type to open the pyranose ring, followed by subjecting the hydroxyl group to oxidation to synthesize the compound [VIII]. [H.-J. Altenbach et al.
Tetrahedron Letters, 26, pp.6329-6332 (1985)]
The compound (7a) can also be produced by, instead of resorting to Step B-5 to B-8, subjecting the oxime (or O-alkyl oxime or aralkyl oxime) obtainable by allowing the compound [I"]to react with hydroxylamine (or O-substituted hydroxylamine such as O-methyl hydroxylamine or O-benzylhydroxylamine) to reduction.
Reduction of the hydroxylimino group of oximes to amino group can be carried out in the state that the hydroxyl group at the cyclitol l33sss4 moiety is protectedl or the reduction may be carried out after eliminating the hydroxyl group to obtain the compound (7b~. The reduction can be conducted by using a metal hydride complex e.g. lithium aluminium hydride.
Specific examples of methyl phosphonic acid ester of the general formula [IX] employed in Step B-l are mentioned dialkyl ester of 1-4 carbon atoms e.g. dimethyl ester, diethyl ester, dipropyl ester, dibutyl ester; ~iaryl ester e.g. diphenyl ester; diaralkyl ester e.g. dibenzyl ester, of methylphosphoric acid. Besides, methods employing methyl diphenyl phosphine oxide in which the (oR5)2 moiety of the compound [IX] is replaced by (C6H5)2 and methyl phosphonic acid bis(dimethylamine) in which the (OR )2 moiety of the compound [IX] is replaced by [(CH3)2N]2 are also included in the category of the method employing methylphosphonic acid ester. The reaction is normally conducted at -78C to 40C, especially at the initial stage of the reaction, the reaction is conducted by cooling to about -78C, preferably in an atmosphere of an inert gas e.g.
argon, nitrogen, e~c. The reaction time varies depending upon the reaction temperatures and is normally in the range of 30 minutes to 3 hours.
Reagents employable for reducing carbonyl group to hydroxyl group in Step B-2 and B-5 are exemplified by metal hydride complexes, diborane, substituted diborane, etc., more specif-ically boron hydride complex such as sodium borohydride, potassium borohydride, lithium borohydride, zinc borohydride, sodium trimethoxyborohydride, potassium tri-sec-butylboro-hydride, lithium tri-sec-butylborohydride, sodium tri-sec-butylborohydride, potassium trisiamyl borohydride, lithiumtriamylborohydride, etc.' alkali metal cyanoborohydride such as sodium cyanoborohydride, tetra-n-butylammonium cyanoboro-hydride, etc.; alkali metal aluminium hydride such as lithium aluminium hydride, lithium trimethoxyaluminium hydride, lithium tri(tert-butoxy)aluminium hydride, etc.; alkyl borane such as 2,3-dimethyl-2-butyl borane, bis-3-methyl-2-butyl borane, diisopinocamphenyl borane, dicyclohexyl borane, 9-borabicyclo[3.3.1]nonane, NB-Enantrane, NB-Enantride, etc., alkylaminoborane such as tetramethyl ammonium borohydride, etc.; etc.
The temperatures for these reduction reactions vary depending upon the type of reducing agents, and normally n the range of from -30C to 40C, and, as the case may be, especially at the initial stage of the reaction under cooling to about -78C, and,when occasion demands,at about 80C. The reaction time also varies depending upon the reaction temperature as well as the type of reducing ayents, and the objective can be achieved by conducting the reaction normally in the range of several minutes to 24 hours.
In Step B-3, for preparing the heptodiulose derivative [Vm]
by oxidizing the unprotected hydroxyl group of the heptitol derivative (3), the reaction condition of oxidizing the secondary hydroxyl group of sugars or polyhydric alcohol to carbonyl group is employed. For example, oxidation by using dimethyl sulfoxide and an activating reagent thereof, namely, dimethyl sulfoxide and trifluoroacetic anhydride; dimethyl sulfoxide and acetic anhdyride;
dimethyl sulfoxide and phosphorus pentoxide; diemthyl sulfoxide and sulfur trioxide - pyridine complex; dimethyl-sulfoxide and oxalyl chloride; etc., is employed, and especially the oxidation by using dimethyl sulfoxide and trifluoroacetic anhydride is preferable. Alternatively, oxidation by using chromium trioxide-pyridine complex, pyridinium dichromate, ruthenium oxide (~), etc. may be employed.
The reaction conditions vary with the type of oxidizing agents, and as to the reaction solvent, for example, use can be made of dichloromethane, chloroform, benzene, toluene, dimethylformamide, dimethylsulfoxide, acetic anhydride, etc., singly or in admixture. The reaction is normally carried out at temperatures in the range of from -10C to 40C, and as the case may be, especially at the initial stage of the 133S89~

- reaction, by cooling to about -78C. The reaction time is in the range of one hour to 24 hours.
The reaction for preparing the unsaturated inosose derivative [I"] in Step B-4, which comprises subjecting the phosphoryl-diketose derivative [V~] to intramolecular ring-closure reaction by treating with a base, belongs to reactions known as intramolecualr Wittig reaction or Wadsworth-Emmons reaction [cf.: W. S. Wadsworth, Jr., Organic Reaction, 24, pp.73-253 (1977); K.B. Becker, Tetraheron, 36, pp.1717-1745 (1980); W. S. Wadsworth, Jr., and W. D. Emmons, J. Amer. Chem. Soc. 83 pp. 1733-1738, (1961)], and methods known in connection with these methods are advantageously employed.
As the base usable for the intramolecular ring-closure reaction of the compound [V m] into the compound [I"], use is made of, for example, alkali metal salts such as potassium carbonate, sodium carbonate, potassium hydrogencarbonate, etc,; alkali metal hydroxides such as potassium hydroxide, sodium hydroxide, etc.; alkali metal hydrides such as sodium hydride, potassium hydride, lithium hydride, etc.;
alkali metal alkoxides such as sodium methoxide, sodium ethoxide, potassium-tert-butoxide, etc.; alkyl alkali metals such as butyllithium, propyllithim, etc. Among the intramolecular ring-closure reactions employing a base for converting the compound [V m] into the compound [I"], preferable one are those employing, as the base, an alkali metal carbonate such as potassium carbonate, sodium carboante, etc.
in the presence of crown ether such as 18-crown-6, dibenzo-18-crown-6, dicyclohexyl-18-crown-6, 15-crown-5, etc. [cf.:
P. A. Aristoff, Synthetic Communication, 13, pp.145-150 (1983)]. The reaction solvent varies depending upon the kind of bases then employed, and, for example, aromatic hydrocarbons such as benzene, toluene, etc., ethers such as tetrahydrofuran, ethylene glycol monoethylether, ethyl-ether, etc. are used advantageously. The reaction time also varies with the kind of bases or reaction solvents, .26_ 1 33589~

and the reaction is conducted normally in the range of 10C
to the boiling point of the solvent, and, as the case may be, the reaction is carried out, especially by cooling to about -78C at the initial stage. The reaction time varies with the reaction temperature, and it is normally in the range of 1 to 18 hours.
As method of preparing the compound (5), in Step B-6, by subjecting the unprotected hydroxyl group of the unsaturated pseudo sugar derivative (4) to organosulfonylati is exemplified a method which comprises allowing the com-pound (4) to react with sulfonyl halides representable by the general formula R6-SO2-X [wherein X stands for a halogen such as chlorine, bromine, iodine, etc., and R6 stands for a lower alkyl group; phenyl group which may optionally substituted by chlorine, bromine, iodine, a lower alkyl group, a lower alkoxy group, nitro group; benzyl group;
naphthyl group and imidazolyl group.] preferably, a method which comprises allowing the compound (4) to react with, for example, methanesulfonyl chloride, p-toluene-sulfonyl chloride, imidazolylsulfonyl chloride. More specifically,a method, which comprises allowing an unsaturated cyclitol derivative to react with sulfonyl halide (more than equimolar, preferably 1.2-3 mol.) in the presence of an organic base (e.g. tertiary amine such as triethylamine, pyridine, etc.) and, as the case may be, in an inert solvent such as dimethylformamide, benzene, toluene, acetone, etc., normally at -30 to 40C and,as the case may be, especially at the initial stage of the reaction, under cooling to about -50C, and, as the case may be, by heating up to about 80C, is mentioned.
~ s the method, in Step B-7,of preparing the azido deriv-ative (6) from the organic sulfonyl derivative (5) is ex-emplified the one which comprises allowing the compound (5) to react with, for example, an alkalimetal azide such as sodium azide, lithium azide, etc., or a lower alkyl ammonium azide such as tetra-n-butyl ammonium azide, etc., in a organic solvent such as benzene, toluene, dimethylformamide, dimethyl acetamide, etc. or a mixed solvent of these solvents and water at an optional combination, normally in the range of -10 to 120C for 1-24 hours.
As the method, in Step B-~, ofpreparing the valienamine derivative (7) by subjecting the azido-derivative (6) to reduction, is exemplified a method of reducing by using an aluminium metal hydride such as lithium aluminium hydride, lithium trimethoxyaluminium hydride, lithium (tert-butoxy)aluminium hydride, etc. More specifically, the compound (7a) can be prepared by subjecting the compound (6) to reaction at -30 to 40C for 1-3 hours in a solvent such as tetrahydrofuran, ethyl ether, etc. using lithium aluminium hydride as the reducing agent.
Besides, as the method of selectively reducing the azido group to amino group, when a double bond is present in the azido-compound, are exemplified the method of reducing using alkali metal borohydride such as sodium borohydride, lithium borohydride, etc., and, as the case may be, in the presence of a phase-transfer catalyst such as hexadecyl tributylphosphonium bromide, etc.; the method of using propane-1,3-dithiol and triethylamine; the method of using chromous chloride (CrCl2); the method of reducing with hydrogen sulfide in pyridine-water; the method of using triphenylphosphine; the method which comprises catalytic reduction using Lindler-catalyst; etc.
When the removal of the protective group of the hydroxyl group of the compound (7a) is ~ec~ss~ry, the objective can be achieved by employ-ing a known conventional deprotection method in accordance with the kind of the protective group then used.
For example, when tetrahydropyranyl group is the protec-tive group for the hydroxyl group, valienamine (7b) can be prepared by conducting hydrolysis for 3-8 hours normally at 30-80C in a mixture solution of acetic acid and water, for example.
Valiolamine can be prepared from the compound (7a) and 133589g the compound (7b) by, for example, the method shown in Scheme 5. Namely, valiolamine can be prepared through the following steps : the step of synthesizing the N-acyl derivative (8) by allowing the compound (7a) or the compound (7b) to react with a carbonylating agent representable by the general formula R7-o-Co-z (wherein Z stands for halogen atom, residue of active ester or residue of carbonic acid ester), the step of synthesizing the cyclic carbamate deriv-ative (9) by allowing the compound (8) to react with a halogenating agent e.g. bromine, the step of synthesizing the compound (10) by reducing with a reductive dehalogenating agent e.g. sodium borohydride, the step of preparing compound (lla) or valiolamine (llb) by subjecting the cyclic carbamate linkage of the compound (10) to hydrolysis, and,if necessary, the step of removing the protective group for the hydroxyl group of the compound (lla).
[Carbohyd. Res., 140, pp. 185-200 (1985)]
In each of the formulae of Scheme 5, R3 stands for h~oy~l atom or a protective group for hydroxyl group, R7 stands for hydrocarbon residue of alkyl, aryl or aralkyl, and X stands for halogen atom. As the hydroxyl protective groups repre-sented by R3, those mentioned above as the hydroxyl protec-tive groups represented by R1 can be similarly employed.
Scheme 5 ~<OR9 ~ ~ ~OR3 ~ > ;~
R30 ~ NH2 R30 ~ NH-CO-OR7 R30 ~'H

(7a):R3= OH protective group (7b):R3= H

~\ ~ R: O ~ ~nll2 (10) (lla):R3= OH protective group (llb):R3 = H

The obtained compounds [I'] and [III] and intermediates for synthesizing them can be isolated and purified by per se known means, for example, filtration, centrifugation, concentration, concentration under reduced pressure, drying, freeze-drying, adsorption, desorption, methods of utilizing difference of solubility to various solvents (e.g. solvent extraction, phasic transfer, precipitation, crystallization, recrystallization, etc.), chromatography (e.g. chromatography using ion-exchange resin, activated charcoal, high porous A 10 polymer, Sephadex, Sephadex ionexchanger, cellulose, ion-exchanging cellulose, silica gel, alumina, etc.), etc.
Salts of the compound [III ] included in this invention are pharmaceu-tically acceptable addition salts of the compound [III ]. As such salts, use is made of the salts of inorganic acids e.g. hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, nitric acid, etc., organic acids e.g. acetic acid, malic acid, citric acid, ascorbic acid, mandelic acid, methanesulfonic acid, etc., etc.
Further, the compound [m] wherein R3is hydrogen atom and the wavy bond ~J~is S-configurational bond, representable by the general formula ~ [ma~
~OH ~
H
HO
[wherein A is hydrogen atom or amine residue] i.e. valio~ine and N-sub-stituted derivatives thereof and their salts are almost free from toxicity (LDso in rats, not lower than 500 mg/kg) and have ~-glucosidase inhibitory activity, and suppress the metabolism of carbohydrates in man and other animals.
Therefor, they suppress the rise of the blood sugar level and are useful for therapy and prophylaxis of hyperglycemic symptoms and various disorders caused by hyperglycemia such as diabetes, prediabetes, obesity, rO~ k -_30_ 1335894 adipositas, hyperlipemia (arterioscelosis) as well as diseases attributable to sugar metabolism by microorganisms in oral cavity (for example, dental carries, etc.).
- The compound [I] is a useful compound comparable to valiolamine as an intermediate for preparing various N-sub$tituted valiolamine derivatives and other valiolamine-relating compounds.
Furth~ ~ re, it has been known that se~h~ptulose usable as the starting material for preparing the compound [I'] is accumulated in a large amount in the culture broth of a certain species of bacteria or actinomycetes, etc., thus sedoheptulose can be prepared less expensively by fermentation production.
Besides, sedoheptulosan or 2,7-anhydro-~-idoheptulopyranose (D-idoheptulosan) can be prepared less expensively by employ-ing sedoheptulose as the starting material, and, therefore,the method of this invention is useful for preparing valiolamine and N-substituted valiolamine derivatives.
The unsaturated inosose derivative [I"] of the present invention is an important compound as starting materials for preparing valienamine, valiolamine via valienamine, and their N-substituted derivatives. The inventors have succeeded in preparing the unsaturated inosose derivative [I'l] via the compound [VIII] which is prepared from D-glucose or D-glucono-1,5-lactone obtainable from D-glucose inexpensively and easily.
The following Reference Examples and Examples illustrate in detail the content of the present invention, but the scope of the present invention should not be limited thereto. The mixture ratiosof the mixed solvents used in Reference Examples and Examples are all shown by V/V, unless otherwise specified.

Reference Example 1 4,5-O-Isopropylidenesedoheptulosan Crystals of sedoheptulosan(2,7-anhydro-~-D-altro-2-heptulo-pyranose, 25 g) were pulverized and suspended in acetone (320 mQ). To the suspension was added conc. sulfuric acid (2.5 mQ), and the mixture was stirred for 18 hours at room temperature. The resulting crystals were collected by filtration and washed with acetone to give 4,5-O-isopropyli-denesedoheptulosan (28 g).
Elemental Analysis for ClOH16O6 Calcd (%) : C, 51.72; H, 6.94 Found (%) : C, 51.58; H, 6.97 Reference Example 2 1,3-Di-O-benzoyl-4,5-O-isopropylidenesedoheptulosan To a suspension of 4,5-O-isopropylidenesedoheptulosan (5.0 g) in a mixture solvent of N,N-dimethylformamide (DMF)(85 mQ) and pyridine (5 mQ) was added dropwise benzoyl chloride (9 mQ) under cooling (about -30C). The mixture was stirred for further 2.5 hours at -5 to -10C. The reaction solution was added to ice-water (about 200 mQ) and the resulting oily product was subjected to extraction with ethyl acetate.
The ethyl acetate extract solution was washed with 2N
hydrochloric acid and saturated sodium hydrogencarbonate solution, which was then dried over anhydrous sodium sulfate.
The solvent was distilled off under reduced pressure, and the residue was subjected to a silica gel column chromato-graphy (500 mQ), followed by elution with toluene - ethyl acetate (10 : 1). The eluate fractions were combined and concentrated to dryness under reduced pressure, and the residue was dried overnight under reduced pressure to give 1,3-di-O-benzoyl-4,5-O-isopropylidenesedoheptulosan as a while powder (8.8 g).
Reference Example 3 1,3-Di-O-benzoylsedoheptulosan In 80% acetic acid (90 mQ) was dissolved 1,3-di-O-benzoyl-4,5-O-isopropylidenesedoheptulosan (8.8 g), and the solution was stirred at 70 to 75C for 2 hours. To the reaction -32- 133589~
solution was added water (170 mQ), which was concentrated under reduced pressure. The concentrate was dissolved in ethyl acetate, which was washed with saturated sodium hydrogencarbonate solution. The resultant was dried over anhydrous sodium sulfate, followed by distilling off the solvent. To the residue was added ethyl ether-petroleum ether (3 : 1 )(280 mQ). The mixture was left standing overnight in a refrigerator to give 1,3-di-O-benzoylsedo-heptulosan as crystals (7.3 g).
Reference Example 4 1,3,4-Tri-O-benzoylsedoheptulosan Tb a solution of 1,3-di-O-benzoyl~e~hh~rtulosan (14.1 g) in dichloro-methane (140 mQ) was added pyridine (4.7 mQ), to which was added dropwise under cooling (-40C or below) a solution of benzoyl chloride (5.64 g) in dichloromethane (50 mQ).
The mixture was stirred for 2.5 hours under cooling (-40 to -30C). The reaction solution was poured into ice-water, which was stirred for 30 minutes. The dichloromethane layer was-separated, and the aqueous layer was subjected to ex~raction with dichloromethane. The dichloromethane extract was washed with 2N hydrochloric acid and saturated sodium hydrogencarbonate solution, followed by drying over anhydrous sodium sulfate. From the resultant was distilled off the solvent under reduced pressure. To the residue was added ethyl ehtyl-petroleum ether (l:lO)(lQ). The mixture was left standing overnight in a refrigerator to give crystals (17.5 g) of 1,3,4-tri-O-benzoylsedoheptulo-san. Elemental Analysis for C28H2 409 Calcd. (%) : C, 66.66 ; H, 4.80 Found (%) : C, 67.04 ; H, 4.74 ~ 3~ 1335894 ,~T ~ R (CDCl 3) ~: 2.51(1H.d,J= 6Hz,-OH),3.9 - 4.2~(2H,m,7-CH2),4.25 - 4.5( lH,m,5-CH;
changed to ~ 4.38(dd,J= 3Hz,5Hz) by the addition of D2O], 4.58(2H,s,l-CH2),4.7- 4.9(lH,m,6-CH),5.46(1H, dd,J= 3Hz,9Hz,4-CH),5.94(1H,d,J= 9Hz,3-CH), 7.1- 7.7(5H,m ) and 7.8- 8.2(6H.m)(C6HsX 3) Reference Example 5 1,3,4-Tri-O-benzoyl-5-O-(imidazolylsulfonyl)sedoheptulo-san In DMF (100 mQ) was dissolved 1,3,4-tri-O-benzoylsedohep-tulosan (9.48 g). To the solution was added under cooling at -40C or below sulfuryl chloride (3.2 mQ), and the mixture was stirred at about -40C for 20 minutes. The reaction solution was again cooled to -40C or below, to which was added imidazole (13.6 g). The cooling bath was removed, and then the mixture was stirred at room temper-ature for 1.5 hour. The reaction solution was poured into ice-water (300 mQ), and the resulting oily substance was subjected to extraction with ethyl acetate. The ethyl acetate extract solution was washed with 2N hydrochloric acid and saturated sodium hydrogencarbonate soltuion, which was dried over anhydrous sodium sulfate, followed by distil-ling off the solvent under reduced pressrue. The residue was subjected to a silica gel column chromatography (600 mQ), followed by elution with toluen-ethyl acetate (3:2).
The eluate was concentrated under reduced pressure, to which was added petroleum ether (about 100 mQ). The mixture was left standing overnight in a refrigerator to give 1,3,4-tri-O-benzoyl-5-O-(imidazolylsulfonyl)sedoheptulosan as a white powder (9.5 g).

_34_ 1335894 Elemental Analaysis for C3 lH26N2l ,S
Calcd. (5) : C, 58.67 ; H, 4.13 ; N, 4.41 Found (%) : C, 58.71 ; H, 4.10 ; N, 4.43 ~ ~I R (CDCl~ 4.04(1H.dd,J= ~Hz,J= 8Hz,7 - -CH),4.G8(iH,d.J= 8Hz,7-CH),4.~9(2H,s,l-CH 2 ) .
4.7~ -4.90(1H, m 6-CH),~. 27(lH,dd,J= 2.~Hz, 4Hz,a-CH),a.49(1H,dd,J= 4Hz,9.6Hz,4-CH),5.92 io (lH,d,J= 9.~Hz.3-CH), 6. 78,7.1~ and 7.18( each lH,s, imidazole ) 7.2 -7.7(9H, m ) and 7.8 -8. 2(6H m)(C6H5x 3 Reference Example 6 2,7-Anhydro-1,3,4,5-tetra-O-benzoyl-~-D-ido-2-heptulo-pyranose In toluene (140 mQ) was dissolved 1,3,4-tri-O-benzoyl-5-O-(imidazolylsulfonyl)sedoheptulosan (9.5 g), to which was added tetra-n-butylammonium benzoate (11 g), and the mixture was stirred for 3 hours at 100C. The solvent was then distilled off under reduced pressure. The residue was partitioned between ethyl acetate and water, and the aqueous layer was subjected to further extraction with ethyl acetate.
The ethyl acetate layers were combined and washed with 2N
hydrochloric acid and saturated sodium hydrogencarbonate solution, then dried over anhydrous sodium sulfate, followed by distilling off the solvent. The residue was subjected to a silica gel column chromatography (lQ) using a mixture of toluene-ethyl acetate (19:1) as the eluent. The eluate was subjected to concentration to dryness under reduced pressure to give a white powder (6.8 g) of 2,7-anhydro-1,3,4,5-tetra-O-benzoyl-~-D-ido-2-heptulopyranose.
Elemental Analysis for C3 sH2 8l O
Calcd. (%) : C, 69.07 ; H, 4.64 Found (%) : C, 69.34 ; H, 4.67 ~ I R (CDCl 3) ~: 4.02(lH,dd,J= 4.5Hz,8Hz,7-CH),4.aO(lH,d,J= 8Hz,7-CH),4.60(2H,s,l-CH2), 5.10 (lH,t,J= 4.5Hz,6-CH),5.54(lH,dd,J= 4.aHz, 8.5Hz,5-CH),5.80(1H,d,J= 8.5Hz,3-CH),6.80(1H, t,J= 8.aHz,4-CH),7.2 -7.7(12H,m) and 7.8 -8.2(8H,m)(C~HsX 4) Reference Example 7 Methyl 1,3,4,5-tetra-O-benzoyl-D-ido-2-heptulopyranoside In a mixture of methanol (30 mQ) and methyl orthoformate (15 mQ) was dissolved 2,7-anhydro-1,3,4,5-tetra-O-benzoyl-~-D-ido-2-heptulopyranose (3.0 g). To the solution was added zinc chloride (3.0 g), and the mixture was stirred at room temperature for 40 hours. The reaction solution was concentrated under reduced pressure, and the concentrate was partitioned between ethyl acetate and water. The ethyl acetate layer was washed with 2N hydrochloric acid and saturated sodium hydrogencarbonate solution, dried over anhydrous sodium sulfate, followed by distilling off the solvent.
The residue was chromatographed on a column of silica gel (200 m ) with toluene-ethyl acetate (5:1). The eluate was concentrated to dryness under reduced pressure to give a white powder (1.05 g) of methyl 1,3,4,5-tetra-O-benzoyl-D-ido-2-heptulopyranoside.
Elemental Analysis for C36H3 2l 1 Calcd (~) : C, 67.49 ; H, 5.03 Found (%~ : C, 66.98 ; H, 4.74 -.~ ~ R (CDCl 3) ~ 2.36(1H, broad s, -OH), 3.69(3H,s,-OCH3),3.97(1H,dd,J= 6.~Hz,9.5Hz,7 -CH),4.21(lH,dd,J= 7HZ,9.5Hz,7-CH),4.56(2H,s, l-CH2),4.60- 4.75(1H,m,6-CH),~.31(lH,dd,J= 5 Hz,8.~Hz,a-CH),5.~2(1H,d,J= 8.~Hz,3-CH),5.96 (l~,t,J= 8..~Hz.~-CH),7.1~- 7.7(12H, m) and 7.8- ~ 2(8h,m)(C6Hsx ~) Reference Example 8 Methyl 1,3,4,5-tetra-O-benzoyl-7-deoxy-7-iodo-D-ido-2-heptulopyranoside In DMF (16 mQ) was dissolved methyl 1,3,4,5-tetra-O-benzoyl-D-ido-2-heptulopyranoside (950 mg). To the solution were added triphenyl phosphine (1.65 g) and N-iodosuccinimide (1.2 g). The mixture was stirred at room temperature over-night. To the mixture was added ice-water (lO0 mQ~
The resulting oily substance was subjected to extraction with ethyl acetate. The ethyl acetate extract was washed with saturated sodium thiosulfate solution, 2N hydrochloric acid and saturated sodium hydrogencarbonate solution, dried over anhydrous sodium sulfate, followed by distilling off the solvent under reduced pressure. The residue was chrom-atographed on a column of silica gel (200 m~) with toluene -ethyl acetate (lO:l). The eluate was concentrated to dryness under reduced pressure to give a white powder (780 mg) of methyl 1,3,4,5-tetra-O-benzoyl-7-deoxy-7-iodo-D-ido-2-heptulopyranoside.
Reference Example 9 Methyl 1,3,4,5-tetra-O-benzoyl-7-deoxy-L-xylo-2-hept-6-enoulopyranoside[namely, methyl 1,3,4,5-tetra-O-benzoyl-7-deoxy-D-ido-2-hept-6-enoulopyranoside]
In pyridine (5 mQ) was dissolved methyl 1,3,4,5-tetra-O-benzoyl-7-deoxy-7-iodo-D-ido-2-heptulOpyranOside (500 mg).
To the solution was added silver fluoride (1.0 g), which ~37~ 1335894 was stirred at room temeprature for 18 hours. To the reaction solution was added ethyl ether (100 m~J, and insolubles were filtered off and washed with ethyl ether.
The filtrate and the washings were combined and concentrated under reduced pressure. The concentrate was dissolved in ethyl acetate and washed with 2N hydrochloric acid and saturated aqueous sodium hydrogencarbonate,dried over anhydrous sodium sulfate, followed by distilling off the solvent under reduced pressure. The residue was chromatographed on a column of silica gel (100 mQ) using toluene-ethyl acetate (9:1) as the eluent. The sluate was concentrated to dryness under reduced pressure to give a white powder (249 mg) of methyl 1,3,4,5-tetra-O-benzoyl-7-deoxy-L-xylo-2-hept-6-enoulopyranoside.
Elemental Analysis for C3 6H3 0l ~
Calcd. (~) : C, 69.56 ; H, 4.86 Found (%) : C, 70.03 ; H, 5.09 ,~T ~I R (CDCl3) ~ :3.68(3H,s,-OCH3),4,4~(2H, broad s,1 -CH2),~.32(1H,d,J= 9Hz,5-CH or 3-CH),~.64(1H,d,J= 9Hz,3-CH or ~ -CH),~.81 (lH,t,J= gHz,4-CH),~.91 and 6.03 (each lH,s,7-CH2),7.2 -7.7(12H,m) and 7.8 - 8.2(8H,m) (C6~5X 4) Reference Example 10 (lS)-(l(OH),2,4,5/1,3)-1-C-(Hydroxymethyl)-1,2,3,4,5-cyclo-hexanepentol and (lS)-(l(OH),2,4/1,3,5)-1-C-(hydroxymethyl)-1,2,3,4,5-cyclohexanepentol Sodium borohydride (250 mg) was added to a solution of 2D-(2,4,5(OH)/3,5)-2,3,4-tri-O-benzoyl-5-(benzoyloxymethyl)-2,3,4,5-tetrahydroxycyclohexanone (1.0 g) in methanol-tetrahydrofuran (1:1, 30 ml) with cooling (ice-water bath) and stirred for 2 hours at the same temperature. The mixture was concentrated and then partitioned between ethyl acetate and water. The ethyl acetate layer was washed with 2N hydrochloric acid and saturated aqueous sodium hydrogencarbonate, dried with anhydrous sodium sulfate, and then evaporated in vacuo. The residue was dissolved in methanol-acetone-2N sodium hydroxide (2:6:3, 220 ml) and stirred overnight at room temperature. The mixture was evaporated in vacuo. Water (50 ml) was added to the resiAue and then the mixture was filtered. The filtrate was passed trhough a column of Dowex*50W x 8 (H+ type, 250 ml). The column was washed with water and the eluate was concentrlted in vacuo. The residue was choromato-graphed on a column of Dowex lx2 (OH- type, 400 ml) and the column was eluated with water. The eluate was separated to the earlier eluted fraction (570 to 760 ml) and the later eluted fraction (765 to 1050 ml)~ The later eluted fraction was concentraLed in vacuo and re-chromatographed on a column of Dowex lx2 (OH- type, 600 ml). The eluate was again separated to the earlier eluted fraction (0.75 to 1.03 ml) and the later eluted fraction (1.1 to 1.4 1).
The later eluted fraction was concentrated in vacuo then lypophilized to give (lS)-(l(OH),2,4,5/1, 3)-1-C-(hydroxy-methyl)-1,2,3,4,5-cyclohexanepentol (49 mg)as awhite powder.
The earlier eluted fractions of the first and the second Dowex lx2 coumn chromatographic runs were combined, concent-rated in vacuo and then lyophilized to give (lS)-(l(OH),2, 4/1,3,5)-1-C-(hydroxymethyl)-1,2,3,4,5-cyclohexanepentol (68 mg) as a white powder.
(lS)-(l(OH),2,4/1,3,5)-1-C-(hydroxymethyl)-1,2,3,4,5-cyclo-hexanepentol (the earlier eluted isomer):
NMR (D2O) ~:1.63 (lH,dd,J=12Hz, 14Hz), 2.14 (lH,dd,J=5 Hz, 14 Hz), 3.25 - 4.1 (6H, m).
(lS)-(l(OH),2,4,5/1,3)-1-C-(hydroxymethyl)-1,2,3,4,5-cyclo hexanepentol (the later eluted isomer):
NMR (D2O) ~: 1.79 (lH,dd,J=3 Hz, 15.5 Hz), 2.12 (lH,dd, J=4 Hz, 15.6 Hz), 3.4 _ 4.45 (6H, m) *Trade Mark ~39~ 1335894 Reference Example 11 2,3,4,6-Tetra-O-(tetrahydropyranyl)-D-glucono-1,5-lactone To a solution of D-glucono-1,5-lactone (20 g) in N,N-dimethylformamide (50 mQ)was added p-tolunenesulfonic acid (0.5 g). To the mixture was added dropwise with cool-ing with ice-water 3,4-dihydro-2H-pyran (100 mQ), followed by stirring for two hours at the same temperature, then for one hour at room tempera-ture. The reaction solution was added to a mixture of ethyl acetate (1.2Q) and water (0.4Q). The ethyl acetate layer was separated, washed with saturated sodium hydrogencarbonate solution, dried over anhydrous sodium sulfate, followed by concentration under reduced pressure. The residue was sub-jected to a silica gel column chromatography (1.5Q). The column was washed with toluene, and then elution was con-ducted with toluene-ethyl acetate (9:1). The eluate was concentrated and then dried under reduced pressure to give 2,3 r 4,6-tetra-O-(tetrahydropyranyl)-D-glucono-1,5-lactone (54.7 g).
IR : vmaxt 1765 cm~
Elemental Analysis for C26 H42 lo Calcd. (%) : C, 60.68; H, 8.23 Found (%) : C, 61.21; H, 8.17 Reference Example 12 3,4,5,7-Tetra-O-benzyl-l-deoxy-l-(dimethoxyphosphoryl)-D-gluco-2-heptulopyranose In tetrahydrofuran (50 mQ) was dissolved dimethyl methyl-phosphonate(4.4mQ), to which was added dropwise a-solution of n-butyllithium in n-hexane (1.7 M solution, 17 mQ) with cooling (-70 to-78C) in a stream of argon, and the mixture was stirred for 30 minutes. To the solution was added dropwise with cooling at the same temperature a solu-tion of 2,3,4,6-tetra-O-benzyl-D-glucono-1,5-lactone (5.3 g) in tetrahydrofuran (25 mQ). The mixture was stirred for 30 minutes. The cooling bath was removed, and the mixture was allowed to warm to 0C with stirring.

The reaction solution was added to an ice-cooled mixture of 10%(W/V) ammonium chloride solution (100 mQ) and ethyl acetate (300 mQ). The ethyl acetate layer was separated, washed with water, dried over anhydrous sodium sulfate, and then concentrated under reduced pressure. The residue was subjected to a silica gel column chromatography (400 mQ), followed by elution with toluene-ethyl acetate (2:1). The eluate was concentrated under reduced pressure, and dried under reduced pressure to give 3,4,5,7-tetra-O-benzyl-1-deoxy-1-(dimethoxyphosphoryl)-D-gluco-2-heptulopyronose (6.0 g) [~]D6 -12.5 (c=1, CHCQ3) lHNMR(cDcQ3)~ : 1.69(dd, J=15, 19 Hz) and 2.32 (dd, J=15, 18 Hz) (each lH, -CH2P-), 3.60(3H, d, J=11 Hz, -OCH3), 3.66(3H, d, J=11 Hz, -OCH3) Elemental Analysis for C37H43OsP :
Calcd. (%) : C, 67.06; H, 6.54 Found (%) : C, 67.15; H, 6.54 Reference Example 13 3,4,5,7-Tetra-O-(tetrahydropyranyl)-1-deoxy-1-(dimethoxy-phosphoryl)-D-gluco-2-heptulopyranose To a solution of dimethyl methylphosphonate (15.3 mQ) in ethyl ether (300 mQ) was added dropwise with cooling (-70 to -78C) in a stream of argon a solution of n-butyl-lithium in n-hexane (1.6 M solution, 84 mQ), and the mixture was stirred for 30 minutes. To the ~olution was added dropwise with cooling at the same temperature a solu-tion of 2,3,4,6-tetra-O-(tetrahydropyranyl)-D-glucono-1,5-lactone (23.2 g) in ehtyl ether (80 mQ). The mixture was stirred for one hour, then the cooling bath was removed, and then the mixture was allowed to warm to 0C with stirring.
The reaction solution was added to an ice-cooled mixture of 10%(W/V) ammonium chloride solution (250 mQ) and ethyl ether (120 mQ). The ethyl ether layer was separated. The aqueous layer was subejcted to extraction with ethyl ether. The organic layers were combined, washed with water, dried over anhydrous magnesium sulfate, concen--41- 133589~

trated under reduced pressure, and dried further under reduced pressure to give 3,4,5,7-tetra-O-(tetrahydropyranyl)-l-deoxy-l-(dimethoxyphosphoryl)-D-gluco-2-heptulopyranose (26.6 g).
[~]26 +34 6 (C=l CHCQ3) lHNMR(CDCQ3)~: 3.72(6H,d,J=12Hz, -OCH3 x 2) Elemental Analysis for C29 Hsl13P :
Calcd. (%) : C, 54.54; H, 8.05 Found (%) : C, 54.83; H, 8.18 Reference Example 14 3,4,5,7-Tetra-O-benzyl-l-deoxy-l-(dimethoxyphosphoryl)-D-glycero-D-gulo-heptitol and 1,3,4,5-tetra-O-benzyl-7-deoxy-7-(dimethoxyphosphoryl)-D-glycero-L-gulo-heptitol To a solution of 3,4,5,7-tetra-O-benzyl-l-deoxy-l-(dimethoxyphosphoryl)-D-gluco-2-heptulopyranose (13.8 g) in tetrahydrofuran (140 mQ) was added sodium borohydride (1.4 g).
The mixture was stirred overnight at room temperature. The reaction mixture was concentrated under reduced pressure, and the residue was distributed between ethyl acetate (500 mQ) and water (300 mQ). The ethyl acetate layer was washed with water, dried over anhydrous sodium sulfate and concentrated under reduced pressure. The concentrate was subjected to a silica gel column chromatography (550 mQ) with toluene-acetone (2:1). The elute was concentratedunder reduced pressure and dried under reduced pressure to give a mixture (12.4 g) of 3,4,5,7-tetra-O-benzyl-l-deoxy--l-Idimethoxyphosphoryl)-D-glycero-D-gulo-heptitol and 1,3, 4,5-tetra-O-benzyl-7-deoxy-7-(dimethoxyphosphoryl)-D-glycero-L-gulo-heptitol.
[~]D +1.7 (c=l, CHCQ3) lHNMR(CDCQ3) ~: 1.5-2.3 (2H,m,-CH2P-),3.04(2H,broad s, -OHx2), 3.63 and 3.66 (total 6H,d,J=llHz, -OCH 3X 2) Elemental Analysis for C37 H4ssP :
Calcd. (%) : C, 66.86; H, 6.82 ; P, 4.66 Found (%) : C, 66.91; H, 6.93 ; P, 4.81 -42- 133589~

Reference Example 15 3,4,5,7-Tetra-O-(tetrahydropyranyl)-l-deoxy-l-(dimethoxy-phosphoryl)-D-glycero-D-gulo-heptitol and 1,3,4,5-tetra-O-(tetrahydropyranyl)-7-deoxy-7-(dimethoxyphosphoryl)-D-glycero-L-gulo-heptitol To a solution of 3,4,5,7-tetra-O-(tetrahydropyranyl)-l-deoxy-l-(dimethoxyphosphoryl)-D-gluco-2-heptulopyranose (26.6 g) in diethyl ether (300 mQ) was added sodium boro-hydride (3.0 g). The mixture was stirred overnight at room temperature. Insolubles were filtered off and washed with diethyl ether. The filtrate and the washings were combined, washed with 10%(W/V) sodium chloride solution, and dried over anhydrous magnesium sulfate, followed by concen-tration under reduced pressure. The concentrate was chro-matographed on a column of silica gel (lQ) with toluene-acetone (1:1). The eluate was concentrated under reduced pressure and dried under reduced pressure to give a mixture (18.8 g) of 3,4,5,7-tetra-O-(tetrahydropyranyl)-l-deoxy-l-(dimethoxyphosphoryl)-D-glycero-D-gulo-heptitol and 1,3,4,5-tetra-O-(tetrahydropyranyl)-7-deoxy-7-(dimethoxyphosphoryl-D-glycero-L-gulo-heptitol.
[~]26 +12 6 (c=l CHCQ3) Elemental Analysis for C29 Hs3l3P :
Calcd. (%) : C, 54.36; H, 8.34 Found (%) : C, 54.73; H, 8.57 Reference Example 16 3,4,5,7-Tetra-O-benzyl-l-deoxy-l-(dimethoxyphosphoryl)-D-xylo-2,6-heptodiulose A solution of dimethylsulfoxide (8.1 mQ) in dichloro-methane (87 mQ) was cooled at -65C to -75C, to which was added dropwise a solution of trifluoroacetic anhydride (9.83 mQ) in dichloromethane (40 mQ). The mixture was stirred for 30 minutes, to~which was added dropwise a solution of a mixture (11.6 g) of 3,4,5,7-tetra-0-benzyl-1-deoxy-1-(diemthyoxyphosphoryl)-D-glycero-D-gulo-heptitol and 1,3,4,5, -tetra-O-benzyl-7-deoxy-7-(dimethoxyphosphoryl)-D-glycero-L-gulo-heptitol in dichloromethane (80 mQ). The mixture was stirred for one hour at the same temperature. To the reaction mixture while cooling at the same temperature was added dropwise triethylamine (23.2 mQ), and the mixture was stirred for 30 minutes. The cooling bath was removed, and the mixture was allowed to warm to 0C with stirring. The reaction solution was added to an ice-cooled mixture of dichloromethane (300 mQ) and 2N hydro-chloric acid (250 mQ). The dichloromethane layer was sep-arated, washed with a saturated sodium hydrogencarbonate solution, dried over anhydrous magnesium sulfate and con-centrated under reduced pressure. The residue was chro-matographed on a column of silica gel (500 mQ) with toluene-ethyl acetate (1:1). The eluate was concentrated underreduced pressure and dried under reduced pressure to give 3,4,5,7-tetra-O-benzyl-1-deoxy-1-(dimethoxyphosphoryl)-D-xylo-2,6-heptodiulose (11.5 g).
[~]D -28~5O (c=1, CHCQ3) , IR : vc CQ31733, 1704 cm~l (C=0) Elemental Analysis for C37H4~O9P :
Calcd. (%) : C, 67.26; H, 6.25; P, 4.69 Found (%) : C, 67.70; H, 6.32; P, 4.69 Reference Example 17 3,4,5,7-Tetra-O-(tetrahydropyranyl)-1-deoxy-1-(dimethoxy-phosphoryl)-D-xylo-2,6-heptodiulose To a solution of dimethylsulfoxide (9.4 mQ) in dichloro-methane (100 mQ) was added dropwise, while cooling at -65C
to-75C, a solution of trifluoroacetic anhydride (12.3 mQ) in dichloromethane (50 mQ). The mixture was stirred for 30 minutes, to which was then added dropwise a solution of a mixture (14.0 g) of 3,4,5,7-tetra-O-(tetrahydropyranyl)-1-deoxy-1-(dimethoxyphosphoryl)-D-glycero-D-gulo-heptitol and 1,3,4,5-tetra-O-(tetrahydropyranyl)-7-deoxy-7-(dimethoxyphosphoryl)-D-glycero-L-gulo-heptitol in dichloromethane (70 mQ).
The reaction mixture was stirred for one hour at the same temperature. To the solution was added dropwise, while _44_ 1335894 cooling at the same temperature, a solution of tri-ethylamine (27.5 mQ) in dichloromethane (50 mQ), and the mixture was stirred for 30 minutes. The cooling bath was removed, and the mixture was allowed to warm to 0C with stirring. The reaction solution was added an ice-cooled mixture of dichloromethane (200 mQ) and 2N hydrochloric acid (200 mQ). The dichloromethane layer was separated, washed with saturated sodium hydrogencarbonate solution, dried over anhydrous sodium sulfate, and then concentrated under reduced pressure. The residure was chromatographed on a column of silica gel (500 mQ) with toluene-acetone (2:1).
The eluate was concentrated under reduced pressure and dried in vacuo to give 3,4,5,7-tetra-O-(tetrahydropyranyl)-l-deoxy-1-(dimethoxyphosphoryl)-D-xylo-2,6-heptodiulose (12.4 g).
[~]D +39 3 (c=1, CHCQ3) , IR :v max 1738 cm (C=O) Reference Example 18 3,4,5,7-Tetra- O-benzyl-l-deoxy-l-(dimethoxyphosphoryl)-D-gluco-2-heptulopyranose A solution of n-butyllithium in n-hexane (1.6 M solution, 68.8 ml) was added to a soultion of dimethyl methylphos-phonate (13.65 g) in tetrahydrofuran (200 ml) in a stream of argon at -70 to -78C, and then stirred for 30 min. To the solution was added a solution of 2,3,4,6-tetra-O--benzyl-D-glucono-1,5-lactone (29.6 g) in tetrahydrofuran (150 ml) at -70 to -78C. The mixture was stirred for 1 hour at the same temperature. The cooling bath was removed and the mixture was allowed to warm to 0C with stirring. Ice-cold 10% ammonium chloride solution (400 ml) was added to the reaction mixture and the resulting oily substances were extracted with ethyl acetate (1.2 1). The ethyl acetate solution was washed with 2N hydrochloric acid and saturated aqueous sodium hydrogen-carbonate, dried with anhydrous sodium sulfate and then evd~oLdted in vacuo. Ethyl ether-petroleum ether (1:3; 400 ml) was added to the residue and the mixture was refrigerated to give 3,4,5,7-tetra-O-benzyl-l-deoxy-l-(dimethoxyphosphoryl)-D-gluco-2-heptulo--45- 1 3~5 8 94 pyranose (33.1 g) as white crystals; m.p. 112 113;
[~]2D -15.6 (c=l, CHCQ3); lH-n.m.r. (CDCQ3): ~ ].69 (dd, J=15Hz,19Hz) adn 2.32 (dd,J=15Hz,18Hz)(each lH, -CH2-), 3.60(d, 3H, J=l~ Hz, -OCH3), 3.66 (d, 3H, J=llHz, OCH3) ElementalA~lysis for C37H43OgP:
Calcd. (%) : C, 67.06; H, 6.54; P, 4.67 Found (%) : C, 67.09; H, 6.39; P, 4.82 Reference Example 19 4L-4,6/5-Tri(benzyloxy)-3-(benzyloxymethyl)-2-cyclohexenone oxime Hydroxylamine hydrochloride (2.0 g) was added to a solution of 4L-4,6/5-tri(benzyloxy)-3-(benzyloxymethyl)-2-cyclohexenone (2.0 g) in dimethyl sulfoxide (10 ml) and then stirred for 24 hours at room temperature. The mixture was distributed between ethyl acetate (250 ml) and water (150 ml). The organic layer was separated, wahsed with 2N hydrochloric acid and aqueous sodium hydrogenc~rh~n~te, dried with anhydrous sodium sulfate and then e~a~oL~Led in vacuo. me residue was chromatographed on a oolumn of silica gel (250 ml) with toluene-ethyl acetate (10:1).
The eluate (450 to 800 ml) was evaporated and dried in vacuo to give the oxime (1.27 g) as a colorless syrup.
Elemental Analysis for C3sH35NO5:
Cacld. (%) : C, 76.48; H, 6.42; N, 2.55 Found (%) : C, 76.66; H, 6.32; N, 2.35 Example 1 2D-2,3,4-tri-O-benzoyl-(2,4,5(OH)/3,5)-5-(benzoyloxymethyl) -2,3,4,5-tetrahydroxycyclohexanone In 80~ acetone-water (40 mQ) was dissolved methyl 1,3,4,5-tetra-O-benzoyl-7-deoxy-L-xylo-2-hept-6-enoulopyranoside (620 mg). To the solution was added mercuric chloride (275 mg), and the mixture was stirred at room temperature for 8 hours. The reaction solution was concentrated under reduced pressure to a volume of about 20 mQ. To the --46- 133589~

concentrate were added ethyl acetate (100 mQ) and water tlOO mQ). The mixture was stirred, and the ethyl acetate layer was separated, washed with 2N hydrochloric acid andsatU-rated sodium hydrogencarbonate solution, dried over anhydrous sodium sulfate, followed by distilling off the solvent under reduced pressure. The residue was chromatographed on a column of silica gel (60 mQ) with toluene-ethyl acetate (5:1). The eluate was concentrated to dryness under reduced pressure to give a white powder (248 mg) of 2D-2,3,4-tri-0-benzoyl-(2,4,5(0H)/3,5)-5-(benzoyloxymethyl)-2,3,4,5-tetrahydroxycyclohexanone.
Elemental Analysis for C 3 sH2 8 l O
Calcd. (%) : C, 69.07; H, 4.64 Found (%) : C, 68.74; H, 5.03 ~ M R (CDCl 3) ~: 2.38(1H, broad s,-OH), 2.88and 3.04(eachlH ABq . J = 14.5Hz.6-CH2).
4.81(2H s,-CH20-),5.43(1H d, J = 10Hz 4-CH), 5.81(1H,t J = lOHz, 3-CH).6.11(1H.d,J= lOHz.2-~H) 7 2~7.7(2H.m) and 7.8 -8.3(8H m)(c6H5 X 4) ~ ~ ~ D - 2 8 .2(c= 1 C H C 13) Thin-layer chromatography (TLC; silica gel 60F-254, manu-factured by Merck): toluene-ethyl acetate (2:1), Rf 0.52; toluene-acetone(9:1), Rf 0.31; n-hexane ethyl acetate (3:2 ) , Rf 0.38 Solubility : soluble in methanol, ethyl acetate, toluene, acetone, chloroform, insoluble in water, petroleum ether Example 2 (lS)-(l(OH),2,4,5/1,3)-5-[[2-hydroxy-1-(hydroxymethyl)ethyl]
amino]-1-C-(hydroxymethyl)-1,2,3,4-cyclohexanetetrol In acetic acid - ethanol (1:9, 15 mQ~ were dissolved 2D-2,3,4-tri-O-benzoyl-(2,4,5(OH)/3,5)-5-(benzoyloxymethyl)-2,3,4,5-tetrahydroxycyclohexanone (410 mg) and 2-amino-1,3-propanediol (280 mg). The solution was stirred at room temperature for 30 minutes, to which was added sodium cyano-borohydride (300 mg). The mixture was stirred at room tem-perature overnight, The reaction solution was concentrated to dryness under reduced pressure, and the concentrate was dissolved in methanol-acetone-lN sodium hydroxide (1:1:2, io loo mQ). The solution was stirred at room temperature for 5.5 hours, followed by distilling off the organic solvent under reduced pressure. The concentrated solution was ad-justed to pH 1 with 2N hydrochloric acid, which was washed with ethyl acetate. To the resultant was added Dowex 50W x 8 (H , 100 mQ), and the mixture was stirred at room temeper-ature for 30 minutes. The reaction mixture was poured onto a column packed with Dowex 50W x 8 (H+, 50 mQ), then the column was washed with water, followed by performing elution with 0.5 N ammonia water. The eluate was concent-rated under reduced pressure. The concentrate was chromato-graphed on a column of Amberlite*CG-50(NH4 , 250 mQ) with water. The eluate was concentrated under reduced pressure, to which was added ethanol. The mixture was refluxed for 15 minutes, followed by concentration under reduced pressure.
The concentrate (about 2 mQ) was left standing overnight to give a white powder of (ls)-(l(oH)l2~4~5/l~3)-5-[[2-hydr l-(hydroxymethyl)ethyl]amino]-l-C-(hydroxymethyl)-1,2,3,4-cyclohexanetetrol.
t a ~ 24 2 6 . 9 (c= 1 ,H 20) N ~IR (D20)~ :1. a4(1H,dd,J= 3Hz,l~Hz,6-CHâx), 2 . 10 (lH,dd,J= 3Hz,laHz,6-CHeq),2.90(1 H,quint.,J= aHz,-~-CH),3.3~- 4.0(10X,m) *Trade Mark --48-- 133S89~

Example 3 (lS)-(l(OH),2,4,5/1,3)-5-[(2-hydroxyethyl)amino]-1-C-(hydroxymethyl)-1,2,3,4-cyclohexanetetrol and (lS)-(l(OH), 2,4/1,3,5)-5-[(2-hydroxyethyl)amino]-1-C-(hydroxymethyl)-1,2,3,4-cyclohexanetetrol In methanol (50 mQ) were dissolved 2D-2,3,4-tri-O-benzoyl-(2,4,5(OH)/3,5)-5-(benzoyloxymethyl)-2,3,4,5-tetrahydroxy-cyclohexanone (880 mg) and ethanolamine (1.0 mQ). To the solution was added sodium cyanoborohydride (1.0 g), and the mixture was stirred at room temeprature overnight. The reaction solution was concentrated under reduced pressure, and the concentrate was partitioned between water (50 mQ) and ethyl acetate (50 mQ). The ethyl acetate layer was separated, and the aqueous layer was further subjected to extraction with ethyl acetate. Ethyl acetate layers were combined and washed with saturated sodium chloride solution, dried over anhydrous sodium sulfate, followed by concentration under reduced pressure. The concentrate was dissolved in methanol (130 mQ), to which was added lN sodium hydroxide (70 mQ). The mixture was stirred at room temp-erature over night. The reaction soltuion was adjusted to pH 4 with 2N hydrochloric acid, followed by concentration under reduced pressure. The concentrate was partitioned between water (50 mQ) and ethyl acetate (50 mQ). The aqueous layer was separated and washed further with ethyl acetate, which was allowed to be adsorbed on a column of Dowex 50Wx8 (H , 400 mQ). The column was then washed with water, then elution was conducted with 0.5N ammonia water.
The eluate was concentrated under reduced pressure. The concentrate was allowed to be adsorbed on a column of Amberlite CG-50(NH4 ,250 mQ). The column was washed with water, then elution was performed with 0.lN ammonia water.
The eluate was concentrated to dryness under reduced pressure, and the concentrate was chromatographed on a column of Dowex lx2 (OH , 400 mQ), then elution was performed with water. The earlier eluted fractions of the eluate (360-480 ml) ~49~ 133589~

were concentrated under reduced pressure, followed by freeze-drying to give (lS)-(l(OH),2,4/1,3,5)-5-[(2-hydroxyethyl)-amino]-l-C-(hydroxymethyl)-1,2,3,4-cyclohexanetetrol (59 mg), and the later eluted fractions (520-680 mQ) were concentrated under reduced pressure, followed by freeze-drying to give (lS)-(l(OH),2,4,5/1,3)-5-[(2-hdyroxyethyl)amino]-1-C-(hydr-oxymethyl)-1,2,3,4-cyclohexanetetrol (228 mg).
(ls)-(l(oH)~2~4/l~3~5)-5-[(2-hydroxyethyl)amino]-l-c-(hydr oxymethyl)-1,2,3,4-cyclohexanetetrol (the earlier eluted isomer) : ~ ~ R (D20)~ :1.16(1H,t J= 12Hz,6-CHax), 2.50(lH,dd,J= 4Hz,12Hz,6-CHeq),2.50- 3.05(3H, m,5-CH, ~-CH2) 3.25- 3. 9a(7H, m) (lS~-(l(OH),2,4,5/1,3)-5-[(2-hydroxyethyl)amino]-1-C-(hydr-oxymethyl)-1,2,3,4-cyclohexanetetrol (the later eluted isomer) :
~ IR (D20) ~ :1.32(1H,dd,J= 3Hz,13Hz,6-CHax),2.14(1H"dd,J= 3.~Hz,l.-~Hz,6 -CHeq),2.23 - 3.13(2H,m,~-CH2),3.23(1H,q,J= 3Hz,~-CH), 3.33- 4.0(7H,m) Elemental analysis for CgHlgNO6 :
Calcd. (%) : C, 45.56; H, 8.07; N, 5.90 Found (%) : C, 45.59; H, 8.03; N, 5.99 Example 4 (lS)-(l(OH),2,4,5/1,3)-5-[[(R)-~-(hydroxymethyl)benzyl]-amino]-l-C-(hydroxymethyl)-1,2,3,4-cyclohexanetetrol In DMF (45 mQ) were dissolved 2D-(2,4,5(0H)/3,5)-2,3,4-tri-O-benzoyl-5-(benzoyloxymethyl)-2,3,4,5-tetrahydroxy-cyclohexanone (860 mg) and D-phenylglycinol-acetate (950 mg).
To the solution was added sodium cyanoborohydride (650 mg), and the mixture was stirred at 55C for 12 hours. The reaction solution was concentrated under reduced pressure, and the concentrate was partitioned in ethyl acetate (100 mQ) and water (50 mQ). The ethyl acetate layer was washed with 2% acetic -~50- 1335894 acid and saturated sodium hydrogencarbonate solution, dried over anhydrous sodium sulfate, then concentrated under reduced pressure. The concentrate was dissolved in methanol -acetone (5:3, 80 mQ), to which was added lN NaOH (20 mQ), followed by stirring at room temperature for 3.5 hours. The reaction solution was adjusted to pH 3 with 2N HCQ, which was then concentrated under reduced pressure. The concent-rate was partitioned between water (100 mQ) and ethyl acetate (50 mQ). The aqueous layer was separated and washed with ethyl acetate, which was then chromatographed on a column of Dowex 50W x 8 (H+, 150 mQ). The column was washed with water, then elution was conducted by using 0.5 N ammonia water. The eluate was concentrated under reduced pressure, and the concen~dLe was ol,.~"aLographed on a column of ~rlite CG-50 (NH4, 180 m ) with water. The eluate was concentrated under reduced pressure, which was then left standing in a refrig-erator to give N-[(R)-~-(hydroxymethyl)benzyl]valiolamine as white crystals (150 mg), m.p.157-158C.

~ a ~ D - 1 0 . 6 (c= 1 .H 20), - 6 ~ (c= 0 . 1 .\ H C 1) ~-~IR (D20)~ :1. 43(1H,dd,J= 3.~Hz,l~Hz,6-CHax),1.73(1H,dd,J= 3.~Hz,l~ Hz,6-CHeq),3.23 -3.7(4H,m),3.7-4.0(~H,m),7.~ H,s,Ph) Example 5 (lS)-(l(OH),2,4,5/1,3)-5-amino-1-C-(hydroxymethyl)-1,2,3,4 -cyclohexanetetrol (valiolamine) a) To a methanolic solution (200 mQ) of 2D-(2,4,5(0H)/3,5) -2,3,4-tri-O-benzoyl-5-(benzoyloxymethyl)-2,3,4,5-tetra-hydroxycyclohexanone (1.0 g) were added hydroxylamine hydrochloride (400 mg) and pyridine (2 mQ), and the mixture was stirred overnisht at room t~l4~dLure. The reaction solution was concentrated under reduced pressure. The concentrate was partitioned between ethyl acetate (100 mQ) and water (20 mQ), and the ethyl acetate layer was separated, washed with 2N HCQ, saturated sodium hydrogencarbonate solution and water, dried over anhydrous sodium sulfate and concentrated to dryness in vacuo.
, The residue was subjected to a silica gel (ca. 100 mQ) column chromatography. The column was washed with toluene -ethyl acetate (10:1), followed by elution with toluene -ethyl acetate (5:1). The eluate was concentraied to dryness under reduced pressure to aive 2D-(2,4,5(OH)/3,5)-2,3,4-tri-0-benzoyl-5-(benzoyloxymethyl)-2,3,4,5-tetrahydroxycyclohexanone oxime as white powder (410 mg).
b) In methanol (20 mQ) was dissolved the above-mentioned cyclohexanone oxime (410 mg), to which was added conc.
ammonium water (4 mQ). The mixture was stirred at room temperature overnight. To the reaction solution was added water, which was concentrated to dryness under reduced pressure. To the concentrate was further added water, which was concentrated under reduced pressure. To the concentrate (ca. 50 mQ) was added acetic acid (2 mQ), and the mixture was washed with ethyl acetate. The aqueous layer was con-centrated under reduced pressure, then the organic solvent was distilled off. To the residue was added water again to make the whole volume 50 mQ. To this aqueous solution was added platinum dioxide (200 mg), which was stirred at room temperature for 4 hours in a stream of hydrogen. The catalyst was filtered off, and the catalyst was washed with water.
The filtrate and the ~ hinq5 were combined and concentrated to dryness under reduced pressure. The concentrate was subjected to an Amberlite CG-50(NH4+)(180 mQ) column chrom-atography. The column was washed with water (300 mQ),followed by elution with 0.05 N ammonia water. Fractions (1330-1880 mQ) were combined and concentrated under reduced pressure, followed by freeze-drying to give vallolamine as a white powder (69 mg).

-52- 133589~

Example 6 (lS)-(l(OH),2,4,5/1,3)-2,3,4-Tri-O-benzyl-5-[[2-hydroxy-l-(hydroxymethyl)ethyl]amino]-l-C-(benzyloxymethyl)-1~2,3, 4-cyclohexanetetrol (lS)-(l(OH)),2,4/1,3)-2,3,4--Tri-O-benzyl-l-C-(benzyloxy-methyl)-5-oxo-1,2,3,4-cylcohexanetetrol (600 mg) and 2-amino-1,3-propanediol (230 mg) were dissolved in methanol (40 ml), and then stirred 24 hours at room temperature. Sodium borohydride (1.0 g) was added to the mixture with cooling (ice-water bath), and then stirred 16 hours with cooling (ice-water bath). The mixture was concentrated in vacuo and the residue was partitioned between ethyl acetate (140 ml) and water (50 ml). The ethyl acetate layer was washed with water, dried with andhydrous sodium sulfate, and then evaporated in vacuo. The residue was chromato-graphed on a column of silica gel (60 ml) with ethyl acetate.
The eluate was concentrated to dryness in vacuo to give (ls)-(l(OH),2,4,5/1,3)-2,3,4-tri-O-benzyl-5-[[2-hydroxy-l-(hydromethyl)ethyl] ~ no-l-C-(benzylo~methyl)-1,2,3,4-cyclo-hexanetetrol (380 mg) as a white powder:[~]22 +30.0O(c=l, CHCQ3).
Elemental Analysis for C3gH45NO7:
Calcd. (%) : C, 72.70; H, 7.23; N, 2.23 Found (%) : C, 72.43; H, 7.27; N, 2.31 Example 7 (lS)-(l(OH),2,4,5/1,3)-5-[[2-Hydroxy-l-(hydroxymethyl)ethyl]
amino]-l-C-(hydroxymethyl)-1,2,3,4-cyclohexanetetrol (lS)-(l(OH),2,4/5/1,3)-2,3,4-Tri-O-benzyl-5-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-l-C-(hydroxymethyl)-1~2,3,4-cyclohexanetetrol (200 mg) was dissolved in 90% formic acid-methanol (1:19, 20 ml). Palladium black (100 mg) was added to the solution and the mixture was stirred overnight at room temperature in an atmosphere of nitrogen. The catalyst was filtered off and washed with metanol-water (1:1). The BJ35 filtrate and the washings were combined and then evaporated in vacuo.

_53_ 1 3358~4 The residue was chromatographed on a column of Dowex 50 Wx8 (OH type, 70 ml). The column was washed with water and eluted with 0.5N ammonium hydroxide, and the eluate was evaporated in vacuo. The residue was chromatographed on a column of Amberlite CG-50 (NH4 type, 180 ml) with water and the elute was evaporated to dryness in vacuo. Ethanol (10 ml) was added to the residue and then refluxed for 10 minutes. The mixture was refrigerated overnight to give (lS)-(l(OH),2,4,5/1,3)-5-[[2-hydroxy-1-(hydroxymethyl)ethyl]- -amino]-1-C-(hydroxymethyl)1,2,3,4,-cyclohexanetetrol (80 mg) as colorless crystals.
Example 8 4L-4,6/5-Tri(benzyloxy)-3-(benzyloxymethyl)-2-cyclo-hexenone To a solution of 3,4,5,7-tetra-O-benzyl-l-deoxy-l-(di-methoxyphosphoryl)-D-xylo-2,6-heptodiulose (12.5 g) in toluene (500 mQ) were added 18-crown-6 (200 mg~ and potassium car-bonate (8.0 g). The mixture was stirred overnight at room temperature, and then insolubles were filtered off and washed with toluene. The filtrate and the wahings were combined, washed with 2N hydrochloric acid and saturated sodium hydrogencarbonate solution, dried over anhdyrous sodium sulfate, and then concentrated under reduced pressure.
The residue was chromatographed on a column of silica gel (500 mQ) with toluene-ethyl acetate (20:1). The eluate was concentrated under reduced pressure and dried in vacuo to give 4L-4,6/5-tri(benzyloxy)-3-(benzyloxymethyl)-2-cyclohexenone (5.7 g).
[~]D -12.2 (c=1, CHCQ3) , IR :v ma3x 1694 cm~~tC=O) lHNMR(CDCQ3) ~: 6.17 -6.25 (lH, m, 2-CH) 133~89~
Elemental Analysis for C35H34Os :
Calcd. (%) : C, 78.63; H, 6.41 Found (%) : C, 78.83; H, 6.27 Example 9 4L-4,6/5-Tri(tetrahydropyranyloxy)-3-(tetrahydropyranyl-oxymethyl)-2-cyclohexenone a) To a solution of 3,4,5,7-tetra-O-(tetrahydropyranyl)-l-deoxy-l-(dimethoxyphosphoryl)-D-xylo-2,6-heptodiulose (12.1 g)in toluene (500 mQ) were added 18-crown-6 (200 mg) and potassium carbonate (8.0 g), and the mixture was stirred overnight at room temperature. Insolubles were filtered off and washed with toluene. The filtrate and the washings were combined, washed with 2N hydrochloric acid and saturated sodium hydrogencarbonate solution, dried over anhydrous sodium sulfate, and then concentrated under reduced pressure.
The concentrate was chromatographed on a column of silica gel (500 mQ) with toluene-ethyl acetate (3:1). The eluate was concentrated under reduced pressure and dried in vacuo to give 4L-4,6/5-tri(tetrahydropyranyloxy)-3-(tetrahydro-pyranyloxymethyl)-2-cyclohexenone (7.5 g).
b) To a solution of 3,4,5,7-tetra-O-(tetrahydropyranyl)-l-deoxy-l-(dimethoxyphosphoryl)-D-gluco-2-heptulopyranose (6.3 g) in toluene (50 mQ) was added sodium hydride (270 mg).
The mixture was stirred for two hours at room temperature, then insolubles were filtered off. On the other hand, a solution of trifluoroacetic anhydride (5.0 mQ) in dichloro-methane (25 mQ) was added dropwise to a solution of dimethyl-sulfoxide (3.4 mQ) in dichloromethane (25 mQ) under cooling (-65C to -75C), and the mixture was stirred for 30 minutes.
To the solution was added dropwise the above-mentioned toluene solution at the same temperature, and the mixture was stirred for one hour, to which was added dropwise a solution of triethylamine (10 mQ) in dichloromethane (30 mQ) at the same temperature. The mixture was stirred for 10 minutes, then the cooling bath was removed. The mixture was allowed to warm to 0C with stirring. The reaction 133~89~

mixture was added to an ice-cooled mixture of dichloromethane (200 mQ) and water (100 mQ). The dichloro-methane layer was separated, washed with water, dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was dissolved in toluene (70 mQ), to which were added 18-crown-6 (100 mg) and potassium car-bonate (2.0 g). The mixture was stirred for 8 hours at room temperature. To the reaction mixture were added ethyl acetate (150 mQ) and water (50 mQ). The organic layer was separated, washed with 2N hydrochloric acid and saturated solution of sodium hydrogencarbonate, dried over anhydrous sodium sulfate and concetrated under reduced pressure. The concentrate was chromatogrpahed on a column of silica gel (200 mQ) with toluene-ethyl acetate (4:1). The eluate was concentrated under reduced pressure and dried in vacuo to give 4L-4,6/5-tri(tetrahydropyranyloxy)-3-(tetrahydropyranyl-oxymethyl)-2-cyclohexenone (1.3 g).
[~]2 +2.3 (c=l, CHCQ3) , IR : v maHXQ31690 cm~~(C=O) lHNMR(CDCQ3) ~ : 6.14- 6.25(1H,m,2-CH) Elemental Analysis for C27H42 Og :
Calcd. (%) : C, 63.51; H, 8.29 Found (%) : C, 63.94; H, 8.36 Example 10 lL-(l~3/2~4)-2~3~4~-Tri-o-benzyl-5-(benzyloxymethyl)-5 cyclohexene-1,2,3,4-tetrol To a solution of 4L-4,6/5-tri(benzyloxy)-3-(benzyloxy-methyl)-2-cyclohexenone (2,7 g) in tetrahydrofuran-methanol (3:8, 55 mQ) was added dropwise sodium borohydride (270 mg) at -20C. The mixture was stirred for one hour at -15C to -20C. The reaction solution was concentrated under reduced pressure, and the concentrate was distributed between ethyl acetate and water. The ethyl acetate layer was washed with 2N hydrochloric acid and saturated sodium hydrogencarbonate soltuion, dried over anhydrous sodium sulfate, and then concentrated under reduced pressure. The residue was -56- 1 33~89g chromatographed on a column of silica gel (180 mQ) with toluene-ethyl acetate (7:1). The eluate was concentarated under reduced pressure and dried in vacuo to give .lL-(1,3/2,4)-2~3,4-tri-o-benzyl-5-tbenzyloxymethyl)-5-cyclohexene-1,2,3,4-tetrol (2.6 g).
[a]26 -30.9 (c=1, CHCQ3) lHNMR(CDCQ3) ~ : 2.35(1H,s,-OH), 5.90 (lH,broad d,J=5Hz,6-CH) Elemental Analysis for C35H36O5 :
Calcd. (%) : C, 78.33; H, 6.76 Found (%) : C, 78.62; H, 6.74 Example ll lL-(1,3/2,4)-2,3,4-Tri-O-(tetrahydropyranyl)-5-(tetra-hydropyranyloxymethyl)-5-cyclohexene-1,2,3,4-tetrol To a solution of 4L-4,6/5-tri(tetrahydropyranyloxy)-3-(tetrahydropyranyloxymethyl)-2-cyclohexenone (25 g) in methanol (250 mQ) was added sodium borohydride (2.5 g) at -10C to -15C, and the mixture was stirred for 2.5 hours at the same temperature. The reaction solution was concentrated under reduced pressure, and the concentrate was partitioned between ethyl acetate (lQ) and 15%(W/V) sodium chloride solution (500 mQ). The aqueous layer was extracted with ethyl acetate (500 mQ). Ethyl acetate layers were combined, washed with saturated sodium chloride solution, dried over anhydrous sodium sul-fate, followed by concentration under reduced pressure.
The residue was chromatographed on a column of silica gel (l.lQ). The column was washed with toluene-ethyl acetate (2:1) and then eluted with toluene-ethyl acetate (3:2). The eluate was concentrated underreduced pressure and dried in vacuo to give lL-(1,3/2,4)-2,3,4-tri-O-(tetrahydropyranyl)-5-(tetrahydropyranyloxy-methyl)-5-cyclohexene-1,2,3,4-tetrol (13.6 g).
[~]D +2.9 (c=1, CHCQ3) Elemental Analysis for C27 H~ Og :

133S~94 Calcd. (%) : C, 63.26; H, 8.65 Found (%) : C, 63.67; H, 8.63 Example 12 lL-(1,3/2,4)-2,3,4-Tri-O-benZyl-l-O-(imidazolylsulfonyl) 5-(benzyloxymethyl)-5-cyclohexene-1,2,3,4-tetrol To a solution of lL-(1,3/2,4)-2,3,4-tri-O-benzyl-5-(benzyloxymethyl)-5-cyclohexene-1,2,3,4-tetrol (2.5 g) in DMF (20 mQ) was added dropwise sulfuryl chloride (0.79 mQ) at -60C, and the mixture was then stirred for 30 minutes at -40C to -45C. The reaction solution was again cooled to -60C, to which was added imidazole (3.3 g), followed by stirring for one hour at -10C. The reaction mixture was added to an ice-cooled mixture of ethyl acetate (100 mQ) and water (100 mQ). The ethyl acetate layer was separated, and the aqueous layer was extràcted with ethyl acetate (50 mQ). The extract solutions were combined and washed with 2N hydrochloric acid and saturated sodium hydrogencarbonate solution, then dried over anhydrous sodium sulfate, followed by concentration under reduced pressure. The residue was chromatogrpahed on a column of silica gel (150 mQ) with toluene-ethyl acetate (20:1). The eluate was concentrated under reduced pressure and dried in vacuo to give lL-(1,3/2,4)-2,3,4-tri-O-benzyl-l-O-(imidazolylsulfo-nyl)-5-(benzyloxymethyl)-5-cyclohexene-l~2~3~4-tetrol(l.6 g).
[~]D6 -16.7 (c=l, CHCQ3) Elemental Analysis for C38H38N2O7S :
Calcd. (%) : C, 68.45; H, 5.47; N, 4.20; S, 4.81 Found (~) : C, 68.92; H, 5.93; N, 3.99; S, 4.98 Example 13 lL-(l~3/2~4)-l-o-(Imidazolylsulfonyl)-2~3~4-tri-o-(tetra hydropyranyl)-5-(tetrahydropyranyloxymethyl)-5-cyclo-hexene-1,2,3,4-tetrol To a solution of lL-(1,3/2,4)-2,3,4-tri-O-(tetrahydro-pyranyl)-5-(tetrahydropyranyloxymethyl)-5-cyclohexene-1, 2,3,4-tetrol (11.3 q) in DMF (100 mQ) was added dropwise sulfuryl chloride (4.3 mQ) at a temperature of below -60C, and the mixture was stirred for 30 minutes at -40 to -45C. Tne reaction solution was again cooled to -60C or below, to which was added imidazole (14.55 g). The mixture was stirred overnight at 0- 5C, followed by stirring for 3 hours at room temperature. The reaction mixture was added to an ice-cooled mixture of ethyl acetate (lQ) and water (250 mQ). The ethyl acetate layer was separated, washed with water, dried over anhdyrous sodium sulfate and con-centrated under reduced pressure. The residue was chromatographed on a column of silica gel (550 mQ) with toluene-ethyl acetate (5:1). The eluate was concentrated under reduced pressure and dried in vacuo to give lL-(1,3/2,4)-l-O-(imidazolylsulfonyl)-2,3,4-tri-O-(tetrahydropyranyl)-5-(tetrahydropyranyloxymethyl)-5-cyclo-hexene-1,2,3,4-tetrol (8.5 g).
[ ]24 9 oo (c=1, CHCQ3) Elemental Analysis for C30H~ N2OllS :
Calcd. (%) : C, 56.06; H, 7.21; N, 4.36; S, 4.99 Found (%) : C, 55.89; H, 7.34; N, 4.18; S, 5.33 Example 14 lL-1(1~3/2~4)-l-O-(Methanesulfonyl)-2~3~4-tri-O-(tetrahydr pyranyl)-5-(tetrahydropyranyloxymethyl)-5-cyclohexene 1,2,3,4-tetrol To a solution of lL-(1,3/2,4)-2,3,4-tir-O-(tetrahydro-pyranyl)-15-(tetrahydropyranyloxymethyl)-S-cyclohexene-l, 2,3,4-tetrol (2.55 g) in pyridine (20 mQ) was added drop-wise methanesulfonyl chloride (0.77 mQ) at -20C to -30C, and the mixture was then stirred at 0-5C overnight. The reaction solution was concentrated under reduced pressure, and the residue was distributed between ethyl acetate and water. The ethyl acetate layer was washed with 2N
hydrochloric acid and saturated sodium hydrogencarbonate soltuion, dried over anhdyrous sodium sulfate, followed by concentration under reduced pressure. The residue-was chromatographed on a column of silica gel (250 mQ) with toluene-ethyl acetate (4:1). The eluate was -concentrated under reduced pressure and dried in vacuo to give 1 L-(1,3/2,4)-1-O-(methanesulfonyl)-2,3,4-tri-O-(tetra-hydroxypyranyl)-5-(tetrahydropyranyloxymethyl)-5-cyclo-nexene-1,2,3,4-tetrol (1.21 g).
Example 15 lD-(1,3,6/2)-1,2,3-Tri-O-(tetrahydropyranyl)-6-azido-4-(tetrahydropyranyloxymethyl)-4-cyclohexene-1,2,3-triol To a solution of lL-(1,3/2,4)-1-O-(imidazolylsulfonyl)-2,3,4-tri-O-tetrahydropyranyl-5-(tetrahydropyranyloxymethyl)-5-cyclohexne-1,2,3,4-tetrol (1.7 g) in toluene (35 mQ) was added tetra-n-butylammonium azide (1.7 g), and the mixture was stirred-for 2 hours under reflux. To the reaction solution was added ethyl acetate (100 mQ). The mixture was washed with water, dried over anhydrous sodium sulfate, followed by concentration under reduced pressure.
The residue was chromatographed on a column of silica gel (150 mQ) with toluene-ethyl acetate (4:1). The eluate was concentrated under reduced pressure and dried in vacuo to give lD-(l~3~6/2)-l~2~3-tri-o-(tetrahydropyranyl) 6-azido-4-(tetrahydropyranyloxymethyl)-4-cyclohexene-1,2,3-triol (880 mg).
[~]D +62.6 (c=l, CHCQ3) , IR :v max 2100cm l(azido) HNMR(CDCQ3) ~:5.81(1H, broad s, 5-CH) Elemental Analysis for C27 H43N3Os :
Calcd. (%) : C, 60.32; H, 8.06; N, 7.82 Found (~) : C, 60.78; H, 8.32; N, 7.59 Example 16 lD~ 3~6/2)-l~2~3-Tri-o-(tetrahydropyranyl)-6-azido-4 (tetrahydropyranyloxymethyl)-4-cyclohexene-1,2,3-triol To a solution of lL-(1,3/2,4)-1-O-(methanesulfonyl)-2,3,4-tri-O-(tetrahydropyranyl)-5-(tetrahydropyranyloxymethyl)-5-cyclohexene-1,2,3,4-tetrol (1.1 g) in DMF (20 mQ) was added sodium azide (250 mg), and the mixture was stirred for 3 hours at 80C. Tne reaction mixture was concetrated under reduced pressure, and the concentrate was distributed between ethyl acetate and water. The ethyl acetate layer -60- 133589~

was washed with water, dried over anhydrous sodium sulfate, followed by concentration under reduced pressure. The residue was chromatographed on a column of silica gel (100 mQ) with toluene-ethyl acetate (4:1). The eluate was concentrated under reduced pressure and dried in vacuo to give lD-(1,3,6~2)-1,2,3-tri-O-(tetrahydropyranyl)-6-azido-4-(tetrahydropyranyloxymethyl)-4-cyclohexene-1,2,3-triol (1.0 g).
Example 17 lD-(1,3,6/2)-~ri-O-(tetrahydropyranyl)-6-amino-4-(tetra-hydropyranyloxymethyl)-4-cyclohexene-1,2,3-triol[tetra-O-(tetrahydropyranyl)valienamine]
In tetrahydrofuran (47 mQ) was dissolved lD-(1,3,6/2)-1,2,3-tri-O-(tetrahydropyranyl)-6-azido-5-(tetrahydropyranyl-oxvmethyl)-4-cyclohexene-1,2,3-triol (880 mg). To the solu-tion was added by portions lithium aluminium hydride (280 mg) under cooling with ice-water, followed by stirring for 30 minutes at the same temperature then for 1.5 hour at room temperature. The reaction mixture was cooled with ice-water, to which was added dropwise methanol (ca.10 mQ) and then water (ca.10 mQ). The resultant insolubles were filtered off and washed with methanol. The filtrate and the washings were combined and concentrated under reduced pressure. The concentrate was distributed between ethyl acetate and water. The ethyl acetate layer was washed with water, dried over anhydrous sodium sulfate, then concentrated under reduced pressure, followed by drying in vacuo to give tetra-O-(tetrahydropyranyl)valienamine (700 mg).
Example 18 lD-(1,3,6/2)-6-Amino-4-(hydroxymethyl)-4-cyclohexene-1,2,3-triol [valienamine]
A solution of tetra-O-(tetrahydropyranyl)valienamine (700 mg) in 80% acetic acid (35 mQ) was stirred for 5 hours at 50C. The reaction solution was concentrated under reduced pressure. The residue was chromatographed on a column of Dowex 50W x 8 (H+ type, 130 mQ). The column was washed -61- 1 33589q with water, followed by elution with 0.5N
ammonium hydroxide. The eluate was concentrated under reduced pressure. The concentrate was chromatographed on a column of Dowex 1 x 2 (OH type, 180 mQ) with water. The eluate was concentrated under reduced pressure, followed by lyophilization to give valienamine (180 mg).
[~]D +87.6 (c=l, H20) HNMR(D20) ~:5.89(1H,dd,J=1.5, 4.5Hz, 5-CH) l3CNMR(D2o + DCQ) : 50.2(d), 61.9(t), 67.4(d), 71.7(d), io 72.5(d), 116.3(d), 146.5(s) Elemental Analysis for C7Hl3NO4-H20 :
Calcd. (%) : C, 43.52; H, 7.83; N, 7.25 Found (%) : C, 43.67; H, 7.82; N, 7.28

Claims (22)

1. An inosose derivative of the formula (I) (wherein y1 stands for hydroxyl group and y2 stands for hydrogen atom, or y1 and y2 together form a chemical bond between the carbon atoms to which they are attached, and R1 is a protective group for hydroxyl group).
2. An inosose derivative according to claim 1, which is of the formula:

(I') (wherein R1 stands for a protective group for hydroxyl group).
3. An inosose derivative according to claim 1, which is of the formula:

(I") (wherein R1 stands for a protective group for hydroxyl group).
4. A process for preparing an inosose derivative having the formula:

(I') (wherein R1 stands for a protective group for hydroxyl group) which comprises treating a compound having the formula:

(IV) (wherein R4 is hydrogen or a protective group for an anomeric hydroxyl group and R1 is as defined above) with a mercury (II) salt in an aqueous organic solvent.
5. A process for preparing an inosose derivative having the formula:

(I") (wherein R1 stands for a protective group for hydroxyl group) which comprises treating a compound having the formula:

(VIII) (wherein R1 stands for a protective group for hydroxyl group and R5 stands for a hydrocarbon residue)with a base.
6. A process for preparing a pseudoamino sugar of the formula:

(III) wherein R3 stands for hydrogen atom or a protective group for hydroxyl group, A stands for an amine residue or hydrogen atom, and the wavy bond means R- or S-configurational bond, which comprises reacting a compound of the formula:

(I') (wherein R1 stands for a protective group for hydroxyl group) with a primary amine or hydroxylamine having the formula R2-NH2 (wherein R2 stands for an amine residue or hydroxyl group) and then reducing the resultant Schiff's base, followed by, when desired, deprotecting the protected hydroxyl group.
7. A process according to claim 6, wherein the reduction of the Schiff's base is carried out employing a metal complex hydride reducing agent or by a catalytic hydrogenation.
8. A process according to claim 7, wherein the amine of the formula R2-NH2 is hydroxylamine, O-lower alkylhydroxy-lamine or O-lower aralkylhydroxylamine; and the lower alkyl or lower aralkyl group is removed before or after the reduction of the Schiff's base, if applicable, thereby producing a compound of the formula (III) in which A is hydrogen.
9. A process according to claim 7, wherein R2 in the formula R2-NH2 is benzyl or diphenylmethyl, the phenyl group in each of which may be substituted by methoxy; and the benzyl or diphenylmethyl is removed, before or after the reduction of the Schiff's base, thereby producing a compound of the formula (III) in which A is hydrogen.
10. A process according to claim 7, wherein R2 stands for a hydroxyl group or a cyclic or acyclic hydrocarbon group which may have hydroxyl, protected hydroxyl or phenyl which may further be substituted by hydroxyl.
11. A process according to claim 7, wherein the amine of the formula R2-NH2 is:
(a) an acyclic alkylamine which may have hydroxyl or phenyl which may further be substituted by hydroxyl;

(b) an amino-deoxy-alditol;

(c) a cyclic alkylamine optionally having hydroxyl or phenyl;
(d) an inosamine, (e) an C-(aminomethyl)inositol;
(f) a diaminocyclitol; or (g) a pseudo-amino sugar, wherein a hydroxyl group or groups in any of the above amine if present may be protected.
12. A process according to claim 7, wherein the amine of the formula R2-NH2 is:
(a) an acyclic amine selected from the group consisting of ethanolamine, 3-amino-1-propanol, 2-amino-1-propanol, 2-amino-1,3-propanediol, 1-amino-2-propanol, 2-amino-3-hydroxy-1-butanol, tris(hydroxymethyl)aminomethane, 2-amino-2-methyl-1,3-propanediol, 2-amino-2-methyl-1-propanol, 2-amino-3-methyl-1-butanol,3-amino-1,2-propanediol, 4-amino-1,2-butanediol, 2-amino-1-butanol, 2-amino-1,4-butanediol, 2-amino-1,5-pentanediol, 5-amino-1-pentanol, 6-amino-1-hexanol, methylamine, ethylamine, propylamine, butylamine, benzylamine, phenethylamine, aminodiphenylmethane, 2-amino-1-phenylethanol, 2-amino-2-phenylethanol, 2-amino-3-phenyl-1-propanol, 2-amino-3-hydroxy-3-phenyl-1-propanol, 2-amino-3-(4-hydroxyphenyl)-1-propanol, and .beta.-amino-.alpha.-methylphenethylalcohol;
(b) an amino-deoxy-alditol selected from the group consisting of 1-amino-1-deoxy-D-glucitol, 2-amino-2-deoxy-D-glucitol, 1-amino-1-deoxy-D-mannitol, 2-amino-2-deoxy-D-galactitol, 1-amino-1-deoxy-D-ribitol, and 4-amino-4-deoxy-D-erythritol;
(c) a cyclic alkylamine selected from the group consisting of trans-2-aminocyclohexan-1-ol, trans-3-aminocyclo-hexan-1-ol, cis-3-aminocyclohexan-1-ol, trans-2-amino-1-phenylcyclohexan-1-ol, cis-2-amino-1-phenylcyclohexan-1-ol, cyclohexylamine, cyclopentylamine, 1-amino-1-cyclopentane methanol, and 2-aminocyclopentanol;
(d) an inosamine selected from the group consisting of myo-inosamine-1, myo-inosamine-2, myo-inosamine-4, neo-inosamine-2, epi-inosamine-2, muco-inosamine-3, and scyllo-inosamine;
(e) 2-(aminomethyl)myoinositol;
(f) a diaminocyclitol selected from the group consisting of streptamine, deoxystreptamine, fortamine, sporamine, and istamine; or (g) a pseudo-amino sugar selected from the group consisting of valienamine, validamine, hydroxyvalidamine, valiolamine, and 2-hydroxy-4-(hydroxymethyl)cyclopentylamine, wherein a hydroxyl group or groups in any of the above amine if present may be protected.
13. A process according to claim 4, wherein the mercury (II) salt is chloride-, acetate, trifluoroacetate or sulfate.
14. A process according to claim 13, wherein the starting compound of the formula (IV) is produced by:
cleaving the 2,7-anhydro linkage in a compound of the formula:

(VII) (wherein R1 is as defined before), where required followed by introducing a protective group to the anomeric hydroxyl group in the 2-position, to produce a compound of the formula:

(VI) (wherein R1 and R4 are as defined before) halogenating the compound of the formula (VI), to form a compound of the formula:

(V) (wherein X is halogen and R1 and R4 are as defined above), and dehydrohalogenating the compound of the formula (V), to form the compound of the formula (IV).
15. A process according to claim 5, wherein the starting material of the formula (VIII) is produced by:
reacting a glucono-1,5-lactone derivative of the formula:

(1) with a phosphonate carbanion generated by treating a methyl phosphonic acid ester of the formula CH3P(O)(OR5)2 with a base, to form 1-deoxyl-1-phosphoryl-D-gluco-2-heptulopyranose derivative of the formula:

(2) reducing the compound of the formula (2), thereby opening the pyranose ring to form a heptitol derivative of the formula:

(3), and oxidizing the hydroxyl group at the 2- and 6-position of the heptitol derivative (3), to form the compound (VIII).
16. A process according to claim 5 or 6, wherein the ring closure reaction of the compound (VIII) to the compound (I") is carried out using, as the base, an alkali metal carbonate in the presence of a crown ether.
17. 2D-2,3,4-Tri-O-benzoyl-(2,4,5(OH)/3,5)-5-(benzoyloxy-methyl)-2,3,4,5-tetrahydroxycyclohexanone.
18. A process according to claim 7, 8 or 9, wherein the compound (I') is 2D-2,3,4-tri-O-benzoyl-(2,4,5(OH)/3,5)-5-(benzoyloxymethyl)-2,3,4,5-tetrahydroxycyclohexanone.
19. A process according to claim 10, 11 or 12, wherein the compound (I') is 2D-2,3,4-tri-O-benzoyl-(2,4,5(OH)/3,5)-5-(benzoyloxymethyl)-2,3,4,5-tetrahydroxycyclohexanone.
20. A process according to claim 6 or 7, wherein the compound (I') is 2D-2,3,4-tri-O-benzoyl-(2,4,5(OH)/3,5)-5-(benzoyloxymethyl)-2,3,4,5-tetrahydroxycyclohexanone; and the amine of the formula R2-NH2 is 2-amino-1,3-propanediol, ethanolamine, or D-phenylglycinol.
21. 4L-4,6/5-Tri(benzoyloxy)-3-(benzyloxymethyl)-2-cyclohexenone.
22. 4L-4,6/5-Tri(tetrahydropyranyloxy)-3-tetrahydro-pyranyloxymethyl)-2-cyclohexenone.
CA000531094A 1986-03-05 1987-03-04 Inosose derivatives and production thereof Expired - Fee Related CA1335894C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP47941/1986 1986-03-05
JP4794186 1986-03-05
JP116672/1986 1986-05-21
JP11667286 1986-05-21

Publications (1)

Publication Number Publication Date
CA1335894C true CA1335894C (en) 1995-06-13

Family

ID=26388152

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000531094A Expired - Fee Related CA1335894C (en) 1986-03-05 1987-03-04 Inosose derivatives and production thereof

Country Status (7)

Country Link
US (1) US4824943A (en)
EP (1) EP0240175B1 (en)
CA (1) CA1335894C (en)
DE (1) DE3773722D1 (en)
ES (1) ES2040248T3 (en)
GR (1) GR3003110T3 (en)
HU (1) HU199495B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658824B1 (en) * 1990-02-27 1992-07-03 Pf Medicament TRIS ACETYL-2 ", 3", 4 'ETHYLIDENE-4 ", 6" BETA-D-GLUCOPYRANOSIDES, THEIR PREPARATION AND THEIR USE FOR THE PREPARATION OF DEMETHYL-4' EPIPODOPHYLLOTOXIN ETHYLIDENE BETA-D-GLUCOPYRANOSIDE.
JP3110500B2 (en) * 1990-09-03 2000-11-20 大日本明治製糖株式会社 Hypoglycemic inhibitor
JPH04149189A (en) * 1990-10-12 1992-05-22 Japan Tobacco Inc Production of d-altrose
US5516950A (en) * 1994-04-15 1996-05-14 Insmed Pharmaceuticals, Inc. Method for the production of D-chiroinositol
AU3601899A (en) * 1998-03-31 1999-10-18 Bayer Aktiengesellschaft Valiolone, a method of preparing it, and its use to prepare acarbose and voglibose
US7022684B2 (en) 2000-05-24 2006-04-04 Pfizer Inc. Treatment of rumen acidosis with α-amylase inhibitors
US20050165257A1 (en) * 2002-03-27 2005-07-28 Sawai Pharmaceutical Co., Ltd. Process for preparation of voglibose
KR100828032B1 (en) * 2002-11-15 2008-05-08 코오롱생명과학 주식회사 Method of preparing valiolone derivatives
EP1796687A2 (en) * 2004-09-14 2007-06-20 Elixir Pharmaceuticals, Inc. Combination therapy for controlled carbohydrate digestion
KR101136961B1 (en) 2005-08-04 2012-04-19 코오롱생명과학 주식회사 The preparation method of Valiolamine
AP3308A (en) 2011-05-26 2015-06-30 Tfchem Family of aryl, heteroaryl, O-aryl and O-heteroaryl carbasugars
KR20140054800A (en) * 2012-10-29 2014-05-09 주식회사 종근당바이오 Methods of preparing a 1-deoxy-1-(2-hydroxyethyl amino)-d-glucitol and miglitol
CN104119301B (en) * 2013-04-27 2018-05-08 浙江海翔药业股份有限公司 A kind of voglibose intermediate and preparation method thereof
CN110317142B (en) * 2019-07-18 2023-03-28 植恩生物技术股份有限公司 Preparation method of voglibose

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4387219A (en) * 1979-11-13 1983-06-07 Sterling Drug Inc. 2-Hydroxy gentamicin compounds
EP0056194B1 (en) * 1981-01-05 1984-09-12 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars, their production and use
US4446319A (en) * 1981-04-28 1984-05-01 Takeda Chemical Industries, Ltd. Aminocyclitols and their production
US4526784A (en) * 1981-05-05 1985-07-02 Bayer Aktiengesellschaft Amino-cyclitol derivatives and medicaments containing them
US4412068A (en) * 1981-06-08 1983-10-25 Sterling Drug Inc. Novel compounds of the gentamicin class
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same
JPS58203999A (en) * 1982-05-24 1983-11-28 Kaken Pharmaceut Co Ltd Preparation of glucose compound
JPS58213794A (en) * 1982-06-08 1983-12-12 Toshitsugu Yoshimura Preparation of glycopyranosylidene glucose

Also Published As

Publication number Publication date
ES2040248T3 (en) 1993-10-16
EP0240175A1 (en) 1987-10-07
DE3773722D1 (en) 1991-11-21
HUT46031A (en) 1988-09-28
US4824943A (en) 1989-04-25
HU199495B (en) 1990-02-28
EP0240175B1 (en) 1991-10-16
GR3003110T3 (en) 1993-02-17

Similar Documents

Publication Publication Date Title
CA1335894C (en) Inosose derivatives and production thereof
Kraus et al. A direct synthesis of C-glycosyl compounds
JP2015501818A (en) Process for preparing 3-((2S, 5S) -4-methylene-5- (3-oxopropyl) tetrahydrofuran-2-yl) propanol derivatives and useful intermediates thereof
CA1293259C (en) Inosose derivatives, production and use thereof
Just et al. C-Nucleosides and related compounds. XV. The synthesis of D, L-2′-epi-showdomycin and D, L-showdomycin
Nakata et al. Synthetic studies of rifamycins. V. A chiral synthesis of an ansa-chain compound for the C-17-C-29 portion of rifamycin W.
TSUDA et al. Highly stereoselective grignard reaction of an Aldopyranose: A simple synthesis of 6-deoxy-D-idose from D-xylose
Norsikian et al. New and general synthesis of β-C-glycosylformaldehydes from easily available β-C-glycosylpropanones
Barbaud et al. Synthesis of the first pseudosugar-C-disaccharide. A potential antigen for eliciting glycoside-bond forming antibodies with catalytic groups
Khan et al. Synthesis of C-disaccharides an unusual ring closure reaction
Painter et al. Conformation inversion of an inositol derivative by use of silyl ethers: a modified route to 3, 6-di-O-substituted-L-ido-tetrahydroxyazepane derivatives
Bichard et al. Acetonides of α-hydroxy-δ-altronolactones
Grindley et al. A novel approach to the synthesis of C-glycosyl compounds: the Wittig rearrangement
Just et al. Oxidation products of arachidonic acid. IV. Model studies on the attachaient of the C (13)—C (20) side-chain in the synthesis of tetrahydrofurans and pyrans 1, 2, and 3
Yamashita et al. Reactions of 2‐phospholene 1‐oxides with bromine in some media: Facile preparation of bromohydrin derivatives of 2‐phospholenes
JPH0840998A (en) Production of pseudoamino sugar and its derivative by using new inosose derivative as raw material
Barriault et al. Transannular Diels-Alder reaction studies with an activated dienophile. An enantioselective synthesis of an ABC [6.6. 6] trans-syn-cis tricycle
JP3025056B2 (en) Method for producing 2,6-dideoxy-2-fluoro-L-talopyranose derivative
JPH0784403B2 (en) Novel inoseose derivative
HU210045B (en) Process for prepg intermediates for pseudoamino-sugars
Zurabyan et al. Synthesis of a branched tetrasaccharide-2-acetamido-4-o-β-d-galactopyranosyl-6-o-[o-β-galactopyranosyl-(l→ 4)-β-d-glucopyranosyl]-2-desoxy-d-glucose
JPS63119438A (en) Novel unsaturated inosose derivative and production thereof
Kiso et al. Further syntheses of lindane analogs
JP2593677B2 (en) Novel pseudohalosugar derivative and process for producing valiolamine and its derivative using the same as raw material
Ariatti et al. Reaction of carbohydrate halides with magnesium. Novel carbon-carbon coupling of sugar derivatives via organometallic intermediates

Legal Events

Date Code Title Description
MKLA Lapsed